Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter VI Diseases of the nervous system,FALLS,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.96 [0.94-0.97],1.23061268242986e-06,cis
Chapter VI Diseases of the nervous system,FALLS,RSPO3,R-spondin-3,Inverse variance weighted,6,0.84 [0.79-0.9],1.79540994613221e-06,cis
Chapter VI Diseases of the nervous system,FALLS,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,1.14 [1.06-1.23],0.000241278601639234,cis
Chapter VI Diseases of the nervous system,FALLS,AFM,Afamin,Inverse variance weighted,5,0.85 [0.78-0.93],0.00030401839881326,cis
Chapter VI Diseases of the nervous system,FALLS,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.91 [0.87-0.96],0.000760391034299003,cis
Chapter VI Diseases of the nervous system,FALLS,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,1.04 [1.02-1.06],0.000826517742864426,cis
Chapter VI Diseases of the nervous system,FALLS,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.05 [1.02-1.07],0.00126088767436174,cis
Chapter VI Diseases of the nervous system,FALLS,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,0.98 [0.97-0.99],0.00177712930783305,cis
Chapter VI Diseases of the nervous system,FALLS,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.93 [0.88-0.98],0.00391275878435398,cis
Chapter VI Diseases of the nervous system,FALLS,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.02 [1.01-1.04],0.006457727419672,cis
Chapter VI Diseases of the nervous system,FALLS,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.23 [1.06-1.43],0.00696018132709259,cis
Chapter VI Diseases of the nervous system,FALLS,THBS2,Thrombospondin-2,Inverse variance weighted,16,0.97 [0.95-0.99],0.00737781421604882,cis
Chapter VI Diseases of the nervous system,FALLS,CSTB,Cystatin-B,Inverse variance weighted,28,1.03 [1.01-1.06],0.00945799089605569,cis
Chapter VI Diseases of the nervous system,FALLS,IL19,Interleukin-19,Inverse variance weighted,11,0.96 [0.93-0.99],0.00953545821967983,cis
Chapter VI Diseases of the nervous system,FALLS,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.08 [1.02-1.14],0.00966836624131658,cis
Chapter VI Diseases of the nervous system,FALLS,TNR,Tenascin-R,Inverse variance weighted,16,0.97 [0.94-0.99],0.0143491603291241,cis
Chapter VI Diseases of the nervous system,FALLS,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.89 [0.8-0.98],0.0168358434903857,cis
Chapter VI Diseases of the nervous system,FALLS,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.88 [0.79-0.98],0.0182719050611351,cis
Chapter VI Diseases of the nervous system,FALLS,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,0.89 [0.81-0.98],0.018625049805674,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.12 [1.02-1.23],0.0206734643039726,cis
Chapter VI Diseases of the nervous system,FALLS,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.04 [1.01-1.08],0.0213734756106546,cis
Chapter VI Diseases of the nervous system,FALLS,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.06 [1.01-1.11],0.0215168020948482,cis
Chapter VI Diseases of the nervous system,FALLS,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.79 [0.65-0.97],0.0226998081424927,cis
Chapter VI Diseases of the nervous system,FALLS,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.2 [1.03-1.41],0.023221325758464,cis
Chapter VI Diseases of the nervous system,FALLS,NRP1,Neuropilin-1,Inverse variance weighted,12,0.96 [0.93-0.99],0.023423985269164,cis
Chapter VI Diseases of the nervous system,FALLS,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.08 [1.01-1.15],0.0249803622056245,cis
Chapter VI Diseases of the nervous system,FALLS,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.04 [1-1.08],0.0299184791822298,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.02 [1-1.04],0.0300304051259901,cis
Chapter VI Diseases of the nervous system,FALLS,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.03 [1-1.06],0.0320049490832573,cis
Chapter VI Diseases of the nervous system,FALLS,KLK4,Kallikrein-4,Inverse variance weighted,17,0.98 [0.95-1],0.0325795707874402,cis
Chapter VI Diseases of the nervous system,FALLS,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.04 [1-1.08],0.0326214491358811,cis
Chapter VI Diseases of the nervous system,FALLS,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,0.93 [0.87-0.99],0.0329877037060677,cis
Chapter VI Diseases of the nervous system,FALLS,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.92 [0.86-0.99],0.0332196452077225,cis
Chapter VI Diseases of the nervous system,FALLS,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,0.99 [0.98-1],0.0365993762534559,cis
Chapter VI Diseases of the nervous system,FALLS,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,12,1.04 [1-1.07],0.0370988429142359,cis
Chapter VI Diseases of the nervous system,FALLS,OGN,Mimecan,Inverse variance weighted,30,0.98 [0.96-1],0.0396453907927942,cis
Chapter VI Diseases of the nervous system,FALLS,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.03 [1-1.07],0.0423473833451714,cis
Chapter VI Diseases of the nervous system,FALLS,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.12 [1-1.26],0.0443364556197455,cis
Chapter VI Diseases of the nervous system,FALLS,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,1.15 [1-1.32],0.0450133291505821,cis
Chapter VI Diseases of the nervous system,FALLS,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.05 [1-1.11],0.0474908236634595,cis
Chapter VI Diseases of the nervous system,FALLS,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.98 [0.96-1],0.0494370617832496,cis
Chapter VI Diseases of the nervous system,FALLS,REN,Renin,Inverse variance weighted,4,1.04 [1-1.08],0.0500428676596286,cis
Chapter VI Diseases of the nervous system,FALLS,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.03 [1-1.07],0.0503028322577483,cis
Chapter VI Diseases of the nervous system,FALLS,IL32,Interleukin-32,Inverse variance weighted,11,1.04 [1-1.09],0.052222175612373,cis
Chapter VI Diseases of the nervous system,FALLS,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.97 [0.94-1],0.0561624490419413,cis
Chapter VI Diseases of the nervous system,FALLS,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.98 [0.96-1],0.0572300091096854,cis
Chapter VI Diseases of the nervous system,FALLS,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.95 [0.9-1],0.0581876151185731,cis
Chapter VI Diseases of the nervous system,FALLS,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,19,0.98 [0.95-1],0.0595303330626199,cis
Chapter VI Diseases of the nervous system,FALLS,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.79 [0.61-1.01],0.0611516254248714,cis
Chapter VI Diseases of the nervous system,FALLS,COLEC12,Collectin-12,Inverse variance weighted,11,1.04 [1-1.08],0.0631044908941025,cis
Chapter VI Diseases of the nervous system,FALLS,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.02 [1-1.03],0.0648778220204499,cis
Chapter VI Diseases of the nervous system,FALLS,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,0.96 [0.92-1],0.0668236276740602,cis
Chapter VI Diseases of the nervous system,FALLS,CST3,Cystatin-C,Inverse variance weighted,10,0.97 [0.94-1],0.0683404809292486,cis
Chapter VI Diseases of the nervous system,FALLS,LGALS9,Galectin-9,Inverse variance weighted,26,0.98 [0.96-1],0.0703855640645821,cis
Chapter VI Diseases of the nervous system,FALLS,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.94 [0.87-1.01],0.0781174349987487,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.98 [0.96-1],0.0785462617968486,cis
Chapter VI Diseases of the nervous system,FALLS,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.07 [0.99-1.16],0.0821205364555093,cis
Chapter VI Diseases of the nervous system,FALLS,C7,Complement component C7,Inverse variance weighted,38,1.01 [1-1.03],0.0821721876864066,cis
Chapter VI Diseases of the nervous system,FALLS,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.03 [1-1.06],0.0836031011927987,cis
Chapter VI Diseases of the nervous system,FALLS,AREG,Amphiregulin,Inverse variance weighted,3,1.06 [0.99-1.14],0.0845636548112198,cis
Chapter VI Diseases of the nervous system,FALLS,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,1.03 [1-1.07],0.0878314705618106,cis
Chapter VI Diseases of the nervous system,FALLS,IL17C,Interleukin-17C,Inverse variance weighted,3,0.93 [0.86-1.01],0.0898293798566089,cis
Chapter VI Diseases of the nervous system,FALLS,GUCA2A,Guanylin,Inverse variance weighted,9,1.04 [0.99-1.09],0.0905540863388725,cis
Chapter VI Diseases of the nervous system,FALLS,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.26 [0.96-1.65],0.0909652531376555,cis
Chapter VI Diseases of the nervous system,FALLS,CBLN4,Cerebellin-4,Inverse variance weighted,11,0.97 [0.94-1.01],0.0991353542537684,cis
Chapter VI Diseases of the nervous system,FALLS,KLK11,Kallikrein-11,Inverse variance weighted,6,1.02 [1-1.04],0.102418090709161,cis
Chapter VI Diseases of the nervous system,FALLS,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.06 [0.99-1.14],0.103222974822418,cis
Chapter VI Diseases of the nervous system,FALLS,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.07 [0.99-1.15],0.103794854565868,cis
Chapter VI Diseases of the nervous system,FALLS,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,1.05 [0.99-1.1],0.109098386352929,cis
Chapter VI Diseases of the nervous system,FALLS,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.79 [0.59-1.06],0.116825351198323,cis
Chapter VI Diseases of the nervous system,FALLS,PALM2,Paralemmin-2,Inverse variance weighted,8,1.04 [0.99-1.09],0.117570164796483,cis
Chapter VI Diseases of the nervous system,FALLS,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.99 [0.97-1],0.117694035691949,cis
Chapter VI Diseases of the nervous system,FALLS,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.87 [0.73-1.04],0.119636725226316,cis
Chapter VI Diseases of the nervous system,FALLS,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.04 [0.99-1.09],0.126275293159731,cis
Chapter VI Diseases of the nervous system,FALLS,MSLN,Mesothelin,Inverse variance weighted,25,1.01 [1-1.03],0.127280192280322,cis
Chapter VI Diseases of the nervous system,FALLS,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.06 [0.98-1.16],0.131102945135101,cis
Chapter VI Diseases of the nervous system,FALLS,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.03 [0.99-1.07],0.131873073484407,cis
Chapter VI Diseases of the nervous system,FALLS,NECTIN2,Nectin-2,Inverse variance weighted,5,1.02 [0.99-1.05],0.134968978076131,cis
Chapter VI Diseases of the nervous system,FALLS,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.98 [0.96-1.01],0.138438411184943,cis
Chapter VI Diseases of the nervous system,FALLS,LMNB2,Lamin-B2,Wald ratio,1,0.82 [0.63-1.07],0.141221488856632,cis
Chapter VI Diseases of the nervous system,FALLS,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.02 [0.99-1.06],0.144939682775917,cis
Chapter VI Diseases of the nervous system,FALLS,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.03 [0.99-1.06],0.151645131121531,cis
Chapter VI Diseases of the nervous system,FALLS,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.85 [0.67-1.06],0.154922349747872,cis
Chapter VI Diseases of the nervous system,FALLS,CHAD,Chondroadherin,Inverse variance weighted,3,1.02 [0.99-1.06],0.155170144142595,cis
Chapter VI Diseases of the nervous system,FALLS,CDH1,Cadherin-1,Wald ratio,1,1.18 [0.94-1.49],0.156220392579779,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.96 [0.91-1.02],0.158366883594153,cis
Chapter VI Diseases of the nervous system,FALLS,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,0.99 [0.97-1],0.159514541553104,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.98 [0.95-1.01],0.163621328251823,cis
Chapter VI Diseases of the nervous system,FALLS,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,0.99 [0.97-1.01],0.16486004409714,cis
Chapter VI Diseases of the nervous system,FALLS,DSC2,Desmocollin-2,Inverse variance weighted,9,1.03 [0.99-1.07],0.164915960234326,cis
Chapter VI Diseases of the nervous system,FALLS,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.99 [0.96-1.01],0.171688776553404,cis
Chapter VI Diseases of the nervous system,FALLS,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1.15 [0.94-1.4],0.172351192755664,cis
Chapter VI Diseases of the nervous system,FALLS,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.04 [0.98-1.1],0.173331910404617,cis
Chapter VI Diseases of the nervous system,FALLS,CTSV,Cathepsin L2,Inverse variance weighted,11,0.97 [0.94-1.01],0.17498055451342,cis
Chapter VI Diseases of the nervous system,FALLS,ANXA10,Annexin A10,Wald ratio,1,0.87 [0.7-1.07],0.179081226178906,cis
Chapter VI Diseases of the nervous system,FALLS,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,55,1.01 [1-1.02],0.181679345671098,cis
Chapter VI Diseases of the nervous system,FALLS,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,1.01 [1-1.02],0.186664715056869,cis
Chapter VI Diseases of the nervous system,FALLS,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.04 [0.98-1.1],0.196308804599233,cis
Chapter VI Diseases of the nervous system,FALLS,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,17,0.97 [0.93-1.01],0.201130639972062,cis
Chapter VI Diseases of the nervous system,FALLS,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.97 [0.94-1.01],0.203526816848983,cis
Chapter VI Diseases of the nervous system,FALLS,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,0.98 [0.96-1.01],0.2041951963242,cis
Chapter VI Diseases of the nervous system,FALLS,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,1.01 [0.99-1.04],0.204440454703004,cis
Chapter VI Diseases of the nervous system,FALLS,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.93 [0.83-1.04],0.204704710235742,cis
Chapter VI Diseases of the nervous system,FALLS,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.89 [0.74-1.07],0.207632007948653,cis
Chapter VI Diseases of the nervous system,FALLS,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,1.16 [0.92-1.48],0.211812282281892,cis
Chapter VI Diseases of the nervous system,FALLS,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.83 [0.62-1.11],0.212974006008999,cis
Chapter VI Diseases of the nervous system,FALLS,ADIPOQ,Adiponectin,Inverse variance weighted,13,0.97 [0.93-1.02],0.215899340447501,cis
Chapter VI Diseases of the nervous system,FALLS,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,15,1.01 [0.99-1.04],0.216802431037262,cis
Chapter VI Diseases of the nervous system,FALLS,CD48,CD48 antigen,Inverse variance weighted,18,0.99 [0.97-1.01],0.222292662433648,cis
Chapter VI Diseases of the nervous system,FALLS,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.04 [0.98-1.11],0.223949133585557,cis
Chapter VI Diseases of the nervous system,FALLS,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.03 [0.98-1.07],0.225267281371143,cis
Chapter VI Diseases of the nervous system,FALLS,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.01 [0.99-1.03],0.229914615177029,cis
Chapter VI Diseases of the nervous system,FALLS,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.97 [0.93-1.02],0.23094226433197,cis
Chapter VI Diseases of the nervous system,FALLS,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.87 [0.69-1.09],0.2314385390255,cis
Chapter VI Diseases of the nervous system,FALLS,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.03 [0.98-1.08],0.233520539999906,cis
Chapter VI Diseases of the nervous system,FALLS,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.85 [0.65-1.11],0.236100317709777,cis
Chapter VI Diseases of the nervous system,FALLS,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,0.99 [0.97-1.01],0.238074750910472,cis
Chapter VI Diseases of the nervous system,FALLS,CD302,CD302 antigen,Inverse variance weighted,9,0.97 [0.92-1.02],0.239871151919467,cis
Chapter VI Diseases of the nervous system,FALLS,RSPO1,R-spondin-1,Inverse variance weighted,5,0.97 [0.93-1.02],0.240355119803312,cis
Chapter VI Diseases of the nervous system,FALLS,IL10,Interleukin-10,Wald ratio,1,1.06 [0.96-1.18],0.241861589271649,cis
Chapter VI Diseases of the nervous system,FALLS,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,0.99 [0.96-1.01],0.243971397625628,cis
Chapter VI Diseases of the nervous system,FALLS,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.01 [0.99-1.04],0.244753037950095,cis
Chapter VI Diseases of the nervous system,FALLS,MMP8,Neutrophil collagenase,Inverse variance weighted,17,1.01 [0.99-1.04],0.244774755763114,cis
Chapter VI Diseases of the nervous system,FALLS,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.01 [0.99-1.04],0.246146782278781,cis
Chapter VI Diseases of the nervous system,FALLS,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,13,0.98 [0.95-1.01],0.252010654534538,cis
Chapter VI Diseases of the nervous system,FALLS,MMP3,Stromelysin-1,Inverse variance weighted,34,0.99 [0.96-1.01],0.254147014154969,cis
Chapter VI Diseases of the nervous system,FALLS,CD276,CD276 antigen,Inverse variance weighted,20,0.99 [0.97-1.01],0.254544324693509,cis
Chapter VI Diseases of the nervous system,FALLS,PI3,Elafin,Inverse variance weighted,10,0.98 [0.95-1.01],0.254958675204159,cis
Chapter VI Diseases of the nervous system,FALLS,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.01 [0.99-1.04],0.259469285517986,cis
Chapter VI Diseases of the nervous system,FALLS,PRG2,Bone marrow proteoglycan,Wald ratio,1,0.92 [0.8-1.06],0.263099138806804,cis
Chapter VI Diseases of the nervous system,FALLS,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.02 [0.98-1.06],0.264942283871812,cis
Chapter VI Diseases of the nervous system,FALLS,CLEC3B,Tetranectin,Inverse variance weighted,7,1.04 [0.97-1.11],0.26695097980296,cis
Chapter VI Diseases of the nervous system,FALLS,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.98 [0.93-1.02],0.267455760618744,cis
Chapter VI Diseases of the nervous system,FALLS,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.02 [0.98-1.06],0.268144413503451,cis
Chapter VI Diseases of the nervous system,FALLS,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,6,0.96 [0.89-1.03],0.268534153625089,cis
Chapter VI Diseases of the nervous system,FALLS,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,1.02 [0.99-1.05],0.276732799906982,cis
Chapter VI Diseases of the nervous system,FALLS,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,0.99 [0.98-1.01],0.278370077110699,cis
Chapter VI Diseases of the nervous system,FALLS,CNTN5,Contactin-5,Inverse variance weighted,28,1.01 [0.99-1.03],0.286405764400618,cis
Chapter VI Diseases of the nervous system,FALLS,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1.01 [0.99-1.02],0.287411673972592,cis
Chapter VI Diseases of the nervous system,FALLS,PRSS8,Prostasin,Inverse variance weighted,5,1.06 [0.95-1.2],0.288916238783026,cis
Chapter VI Diseases of the nervous system,FALLS,PRTN3,Myeloblastin,Inverse variance weighted,21,1.01 [0.99-1.04],0.289654521946639,cis
Chapter VI Diseases of the nervous system,FALLS,LGALS4,Galectin-4,Inverse variance weighted,4,1.04 [0.97-1.11],0.290672500589873,cis
Chapter VI Diseases of the nervous system,FALLS,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.99 [0.96-1.01],0.29498664116607,cis
Chapter VI Diseases of the nervous system,FALLS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.98 [0.94-1.02],0.299716824252147,cis
Chapter VI Diseases of the nervous system,FALLS,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,1.02 [0.98-1.06],0.300893233435557,cis
Chapter VI Diseases of the nervous system,FALLS,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.04 [0.97-1.12],0.304119987875477,cis
Chapter VI Diseases of the nervous system,FALLS,SHBG,Sex hormone-binding globulin,Inverse variance weighted,11,1.01 [0.99-1.04],0.304267852637689,cis
Chapter VI Diseases of the nervous system,FALLS,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,0.99 [0.98-1.01],0.304335104451773,cis
Chapter VI Diseases of the nervous system,FALLS,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,1.06 [0.94-1.2],0.30603578564301,cis
Chapter VI Diseases of the nervous system,FALLS,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.95 [0.85-1.05],0.307819963206975,cis
Chapter VI Diseases of the nervous system,FALLS,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.06 [0.94-1.2],0.308658674562052,cis
Chapter VI Diseases of the nervous system,FALLS,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.98 [0.94-1.02],0.309243279066624,cis
Chapter VI Diseases of the nervous system,FALLS,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.99 [0.96-1.01],0.312926382550559,cis
Chapter VI Diseases of the nervous system,FALLS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.9 [0.72-1.11],0.314155580120927,cis
Chapter VI Diseases of the nervous system,FALLS,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.02 [0.98-1.06],0.318497374220766,cis
Chapter VI Diseases of the nervous system,FALLS,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,1.02 [0.98-1.07],0.323762814443982,cis
Chapter VI Diseases of the nervous system,FALLS,EDN1,Endothelin-1,Inverse variance weighted,3,0.97 [0.92-1.03],0.324676765086713,cis
Chapter VI Diseases of the nervous system,FALLS,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.01 [0.99-1.04],0.32590119121582,cis
Chapter VI Diseases of the nervous system,FALLS,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.99 [0.96-1.01],0.328538583815521,cis
Chapter VI Diseases of the nervous system,FALLS,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,1.01 [0.99-1.02],0.329754089578053,cis
Chapter VI Diseases of the nervous system,FALLS,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.98 [0.95-1.02],0.331540617945779,cis
Chapter VI Diseases of the nervous system,FALLS,LMOD1,Leiomodin-1,Inverse variance weighted,5,1.06 [0.94-1.2],0.334012491797812,cis
Chapter VI Diseases of the nervous system,FALLS,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.01 [0.99-1.04],0.338131028255592,cis
Chapter VI Diseases of the nervous system,FALLS,LDLR,Low-density lipoprotein receptor,Wald ratio,1,0.81 [0.52-1.26],0.339969392947353,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.95 [0.86-1.05],0.341001301868196,cis
Chapter VI Diseases of the nervous system,FALLS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,1.03 [0.97-1.08],0.345504498344709,cis
Chapter VI Diseases of the nervous system,FALLS,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.99 [0.97-1.01],0.34596840364012,cis
Chapter VI Diseases of the nervous system,FALLS,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.97 [0.9-1.04],0.347851917555532,cis
Chapter VI Diseases of the nervous system,FALLS,ELN,Elastin,Inverse variance weighted,2,1.07 [0.93-1.23],0.350036239373157,cis
Chapter VI Diseases of the nervous system,FALLS,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.97 [0.91-1.04],0.353418620281806,cis
Chapter VI Diseases of the nervous system,FALLS,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,20,1.01 [0.99-1.04],0.357583814269204,cis
Chapter VI Diseases of the nervous system,FALLS,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.96 [0.88-1.05],0.359925191654301,cis
Chapter VI Diseases of the nervous system,FALLS,LAYN,Layilin,Inverse variance weighted,20,1.01 [0.98-1.05],0.364771790995004,cis
Chapter VI Diseases of the nervous system,FALLS,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.94 [0.81-1.08],0.365308546013187,cis
Chapter VI Diseases of the nervous system,FALLS,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,25,0.99 [0.96-1.01],0.368790393186555,cis
Chapter VI Diseases of the nervous system,FALLS,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.97 [0.91-1.04],0.369142527823741,cis
Chapter VI Diseases of the nervous system,FALLS,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.99 [0.95-1.02],0.373412982178731,cis
Chapter VI Diseases of the nervous system,FALLS,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.02 [0.98-1.06],0.380352117395446,cis
Chapter VI Diseases of the nervous system,FALLS,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.05 [0.94-1.16],0.381093515681461,cis
Chapter VI Diseases of the nervous system,FALLS,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,1.02 [0.97-1.08],0.38159228138502,cis
Chapter VI Diseases of the nervous system,FALLS,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.99 [0.96-1.01],0.382466431804717,cis
Chapter VI Diseases of the nervous system,FALLS,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.03 [0.97-1.09],0.382608852674075,cis
Chapter VI Diseases of the nervous system,FALLS,SPP1,Osteopontin,Inverse variance weighted,8,0.95 [0.84-1.07],0.385203405989783,cis
Chapter VI Diseases of the nervous system,FALLS,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.9 [0.7-1.15],0.38629246616164,cis
Chapter VI Diseases of the nervous system,FALLS,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.02 [0.98-1.05],0.392236591822991,cis
Chapter VI Diseases of the nervous system,FALLS,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.02 [0.98-1.05],0.392907474034259,cis
Chapter VI Diseases of the nervous system,FALLS,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,0.99 [0.97-1.01],0.394078386807496,cis
Chapter VI Diseases of the nervous system,FALLS,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.01 [0.98-1.05],0.394598444870145,cis
Chapter VI Diseases of the nervous system,FALLS,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,6,1.03 [0.96-1.11],0.397745085995584,cis
Chapter VI Diseases of the nervous system,FALLS,PENK,Proenkephalin-A,Inverse variance weighted,19,1.01 [0.98-1.04],0.397896259661076,cis
Chapter VI Diseases of the nervous system,FALLS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.03 [0.96-1.11],0.400285755507575,cis
Chapter VI Diseases of the nervous system,FALLS,APOA2,Apolipoprotein A-II,Wald ratio,1,1.07 [0.91-1.26],0.400754341267832,cis
Chapter VI Diseases of the nervous system,FALLS,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,15,0.99 [0.97-1.01],0.409751829948276,cis
Chapter VI Diseases of the nervous system,FALLS,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.02 [0.97-1.07],0.411291058759246,cis
Chapter VI Diseases of the nervous system,FALLS,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,0.99 [0.97-1.01],0.412955316307653,cis
Chapter VI Diseases of the nervous system,FALLS,VCAN,Versican core protein,Inverse variance weighted,31,1.01 [0.99-1.03],0.413317871628479,cis
Chapter VI Diseases of the nervous system,FALLS,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,0.98 [0.95-1.02],0.417497386696409,cis
Chapter VI Diseases of the nervous system,FALLS,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.99 [0.98-1.01],0.422828037368159,cis
Chapter VI Diseases of the nervous system,FALLS,GRN,Progranulin,Inverse variance weighted,7,0.98 [0.95-1.02],0.423462613895121,cis
Chapter VI Diseases of the nervous system,FALLS,RETN,Resistin,Inverse variance weighted,9,0.99 [0.97-1.02],0.424173601602757,cis
Chapter VI Diseases of the nervous system,FALLS,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.04 [0.95-1.14],0.424808458522775,cis
Chapter VI Diseases of the nervous system,FALLS,CD83,CD83 antigen,Inverse variance weighted,5,0.98 [0.93-1.03],0.42947463416509,cis
Chapter VI Diseases of the nervous system,FALLS,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.02 [0.97-1.09],0.430751711180334,cis
Chapter VI Diseases of the nervous system,FALLS,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.99 [0.98-1.01],0.431224455606263,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.02 [0.97-1.08],0.434823597171561,cis
Chapter VI Diseases of the nervous system,FALLS,MATN2,Matrilin-2,Inverse variance weighted,18,1.01 [0.98-1.05],0.436095330036954,cis
Chapter VI Diseases of the nervous system,FALLS,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,1.03 [0.95-1.12],0.438452564298766,cis
Chapter VI Diseases of the nervous system,FALLS,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,21,1.01 [0.99-1.03],0.439091256243448,cis
Chapter VI Diseases of the nervous system,FALLS,CCN4,CCN family member 4,Inverse variance weighted,27,0.99 [0.97-1.01],0.45180866582385,cis
Chapter VI Diseases of the nervous system,FALLS,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.96 [0.88-1.06],0.455441897987799,cis
Chapter VI Diseases of the nervous system,FALLS,LGALS3,Galectin-3,Inverse variance weighted,25,1.01 [0.98-1.04],0.455591364841393,cis
Chapter VI Diseases of the nervous system,FALLS,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,0.99 [0.97-1.02],0.45859685875198,cis
Chapter VI Diseases of the nervous system,FALLS,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.01 [0.98-1.04],0.463993378607822,cis
Chapter VI Diseases of the nervous system,FALLS,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.02 [0.97-1.06],0.466487263391995,cis
Chapter VI Diseases of the nervous system,FALLS,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.07 [0.9-1.27],0.469449535844943,cis
Chapter VI Diseases of the nervous system,FALLS,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.02 [0.97-1.06],0.472507946354636,cis
Chapter VI Diseases of the nervous system,FALLS,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.98 [0.94-1.03],0.474039067466668,cis
Chapter VI Diseases of the nervous system,FALLS,CALCA,Calcitonin,Inverse variance weighted,5,1.05 [0.92-1.19],0.475449062687742,cis
Chapter VI Diseases of the nervous system,FALLS,NECTIN4,Nectin-4,Inverse variance weighted,7,0.99 [0.96-1.02],0.475790828716762,cis
Chapter VI Diseases of the nervous system,FALLS,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.01 [0.98-1.04],0.483590547586792,cis
Chapter VI Diseases of the nervous system,FALLS,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.99 [0.97-1.02],0.493270729795668,cis
Chapter VI Diseases of the nervous system,FALLS,CCN3,CCN family member 3,Inverse variance weighted,19,1.01 [0.98-1.04],0.494630312671266,cis
Chapter VI Diseases of the nervous system,FALLS,CD7,T-cell antigen CD7,Inverse variance weighted,8,0.99 [0.97-1.02],0.49612296288258,cis
Chapter VI Diseases of the nervous system,FALLS,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1 [0.99-1.01],0.497709773216033,cis
Chapter VI Diseases of the nervous system,FALLS,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,1.01 [0.98-1.04],0.498365358434979,cis
Chapter VI Diseases of the nervous system,FALLS,BCAN,Brevican core protein,Inverse variance weighted,3,0.98 [0.94-1.03],0.498925039078868,cis
Chapter VI Diseases of the nervous system,FALLS,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.96 [0.85-1.08],0.502980128970878,cis
Chapter VI Diseases of the nervous system,FALLS,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.02 [0.96-1.09],0.504768026987841,cis
Chapter VI Diseases of the nervous system,FALLS,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.98 [0.94-1.03],0.506740485882447,cis
Chapter VI Diseases of the nervous system,FALLS,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.99 [0.95-1.02],0.50865232248622,cis
Chapter VI Diseases of the nervous system,FALLS,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,0.91 [0.68-1.21],0.510459700966495,cis
Chapter VI Diseases of the nervous system,FALLS,CTSL,Cathepsin L1,Wald ratio,1,0.93 [0.73-1.17],0.511071234442886,cis
Chapter VI Diseases of the nervous system,FALLS,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.93 [0.74-1.17],0.514604737383387,cis
Chapter VI Diseases of the nervous system,FALLS,IL15,Interleukin-15,Wald ratio,1,0.72 [0.27-1.95],0.515730089641485,cis
Chapter VI Diseases of the nervous system,FALLS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.97 [0.88-1.07],0.516172045331904,cis
Chapter VI Diseases of the nervous system,FALLS,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.02 [0.96-1.07],0.519637583958593,cis
Chapter VI Diseases of the nervous system,FALLS,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.02 [0.97-1.07],0.535941350031289,cis
Chapter VI Diseases of the nervous system,FALLS,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.99 [0.96-1.02],0.536704792372537,cis
Chapter VI Diseases of the nervous system,FALLS,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.99 [0.95-1.03],0.537609019647358,cis
Chapter VI Diseases of the nervous system,FALLS,IFNL1,Interferon lambda-1,Wald ratio,1,1.08 [0.84-1.38],0.537874741520434,cis
Chapter VI Diseases of the nervous system,FALLS,CHGB,Secretogranin-1,Inverse variance weighted,27,1.01 [0.99-1.02],0.539211960490658,cis
Chapter VI Diseases of the nervous system,FALLS,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.98 [0.92-1.04],0.54072579138759,cis
Chapter VI Diseases of the nervous system,FALLS,CX3CL1,Fractalkine,Inverse variance weighted,9,0.98 [0.94-1.03],0.541269153962378,cis
Chapter VI Diseases of the nervous system,FALLS,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,0.99 [0.97-1.02],0.543339255685845,cis
Chapter VI Diseases of the nervous system,FALLS,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.04 [0.92-1.16],0.547186201690596,cis
Chapter VI Diseases of the nervous system,FALLS,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.02 [0.97-1.07],0.547986204017356,cis
Chapter VI Diseases of the nervous system,FALLS,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.99 [0.96-1.02],0.559640185963448,cis
Chapter VI Diseases of the nervous system,FALLS,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.99 [0.94-1.03],0.560995553470609,cis
Chapter VI Diseases of the nervous system,FALLS,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.01 [0.97-1.05],0.561061400105705,cis
Chapter VI Diseases of the nervous system,FALLS,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.99 [0.95-1.03],0.561073864926781,cis
Chapter VI Diseases of the nervous system,FALLS,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.95 [0.8-1.13],0.56129655064319,cis
Chapter VI Diseases of the nervous system,FALLS,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.01 [0.99-1.02],0.561675458994616,cis
Chapter VI Diseases of the nervous system,FALLS,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,1 [0.99-1.01],0.566050889148432,cis
Chapter VI Diseases of the nervous system,FALLS,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.99 [0.96-1.02],0.571504296870984,cis
Chapter VI Diseases of the nervous system,FALLS,MDK,Midkine,Inverse variance weighted,4,1.03 [0.92-1.15],0.571721396899198,cis
Chapter VI Diseases of the nervous system,FALLS,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,1.01 [0.98-1.03],0.572045455567202,cis
Chapter VI Diseases of the nervous system,FALLS,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,0.97 [0.86-1.09],0.575903383079627,cis
Chapter VI Diseases of the nervous system,FALLS,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.03 [0.94-1.12],0.580630627115408,cis
Chapter VI Diseases of the nervous system,FALLS,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.01 [0.98-1.04],0.585525837648591,cis
Chapter VI Diseases of the nervous system,FALLS,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.04 [0.91-1.18],0.588774960793086,cis
Chapter VI Diseases of the nervous system,FALLS,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.97 [0.86-1.09],0.593959139450846,cis
Chapter VI Diseases of the nervous system,FALLS,GHR,Growth hormone receptor,Inverse variance weighted,38,1 [0.99-1.02],0.596835207261775,cis
Chapter VI Diseases of the nervous system,FALLS,RBP2,Retinol-binding protein 2,Wald ratio,1,1.05 [0.88-1.25],0.598373661705966,cis
Chapter VI Diseases of the nervous system,FALLS,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.99 [0.96-1.02],0.602868413248335,cis
Chapter VI Diseases of the nervous system,FALLS,MILR1,Allergin-1,Inverse variance weighted,33,1 [0.98-1.01],0.608997733303523,cis
Chapter VI Diseases of the nervous system,FALLS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1 [0.99-1.02],0.609073754701005,cis
Chapter VI Diseases of the nervous system,FALLS,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,0.98 [0.89-1.07],0.609306003447637,cis
Chapter VI Diseases of the nervous system,FALLS,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.98 [0.89-1.07],0.609306003447637,cis
Chapter VI Diseases of the nervous system,FALLS,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.02 [0.93-1.13],0.609946673962405,cis
Chapter VI Diseases of the nervous system,FALLS,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.01 [0.97-1.05],0.612095769286272,cis
Chapter VI Diseases of the nervous system,FALLS,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,0.99 [0.95-1.03],0.612407064299286,cis
Chapter VI Diseases of the nervous system,FALLS,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.92 [0.68-1.26],0.613807614202188,cis
Chapter VI Diseases of the nervous system,FALLS,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.99 [0.95-1.03],0.614279471247453,cis
Chapter VI Diseases of the nervous system,FALLS,DSG2,Desmoglein-2,Inverse variance weighted,11,1.01 [0.97-1.05],0.617935081370113,cis
Chapter VI Diseases of the nervous system,FALLS,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,8,0.99 [0.96-1.03],0.623036834996721,cis
Chapter VI Diseases of the nervous system,FALLS,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1.01 [0.97-1.06],0.626697698148532,cis
Chapter VI Diseases of the nervous system,FALLS,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,1 [0.98-1.01],0.627204702067652,cis
Chapter VI Diseases of the nervous system,FALLS,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,0.99 [0.96-1.03],0.631490112962362,cis
Chapter VI Diseases of the nervous system,FALLS,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1 [0.99-1.01],0.64256337305481,cis
Chapter VI Diseases of the nervous system,FALLS,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,1.01 [0.98-1.04],0.643863654383768,cis
Chapter VI Diseases of the nervous system,FALLS,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,4,1.03 [0.9-1.18],0.645892329862685,cis
Chapter VI Diseases of the nervous system,FALLS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.01 [0.97-1.05],0.649576807443241,cis
Chapter VI Diseases of the nervous system,FALLS,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.01 [0.96-1.06],0.654949088708537,cis
Chapter VI Diseases of the nervous system,FALLS,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,1.03 [0.9-1.17],0.655085433949945,cis
Chapter VI Diseases of the nervous system,FALLS,ITGAM,Integrin alpha-M,Inverse variance weighted,3,0.99 [0.93-1.05],0.656505002601476,cis
Chapter VI Diseases of the nervous system,FALLS,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.99 [0.96-1.03],0.660853588649908,cis
Chapter VI Diseases of the nervous system,FALLS,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1 [0.99-1.02],0.661116059170499,cis
Chapter VI Diseases of the nervous system,FALLS,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.02 [0.93-1.12],0.662584826652903,cis
Chapter VI Diseases of the nervous system,FALLS,CDHR5,Cadherin-related family member 5,Inverse variance weighted,28,1 [0.99-1.02],0.663229762971753,cis
Chapter VI Diseases of the nervous system,FALLS,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.99 [0.96-1.02],0.668460186148423,cis
Chapter VI Diseases of the nervous system,FALLS,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.99 [0.94-1.04],0.668750371581158,cis
Chapter VI Diseases of the nervous system,FALLS,MUC13,Mucin-13,Inverse variance weighted,9,0.99 [0.95-1.03],0.668780182517556,cis
Chapter VI Diseases of the nervous system,FALLS,MSTN,Growth/differentiation factor 8,Inverse variance weighted,2,1.02 [0.93-1.12],0.669361152963287,cis
Chapter VI Diseases of the nervous system,FALLS,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,1.01 [0.98-1.03],0.670931298664298,cis
Chapter VI Diseases of the nervous system,FALLS,PLXNB2,Plexin-B2,Inverse variance weighted,27,1 [0.99-1.02],0.672039105665312,cis
Chapter VI Diseases of the nervous system,FALLS,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,1.03 [0.89-1.19],0.6777265033874,cis
Chapter VI Diseases of the nervous system,FALLS,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,1.02 [0.94-1.1],0.681030757847359,cis
Chapter VI Diseases of the nervous system,FALLS,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.99 [0.92-1.05],0.682375575829171,cis
Chapter VI Diseases of the nervous system,FALLS,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1 [0.98-1.02],0.692552069832055,cis
Chapter VI Diseases of the nervous system,FALLS,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.01 [0.96-1.07],0.693468467577763,cis
Chapter VI Diseases of the nervous system,FALLS,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1 [0.99-1.02],0.698053501748504,cis
Chapter VI Diseases of the nervous system,FALLS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.99 [0.92-1.06],0.698572487734121,cis
Chapter VI Diseases of the nervous system,FALLS,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.01 [0.94-1.09],0.700694172418979,cis
Chapter VI Diseases of the nervous system,FALLS,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.01 [0.97-1.05],0.70662002550041,cis
Chapter VI Diseases of the nervous system,FALLS,AMBP,Protein AMBP,Inverse variance weighted,3,0.99 [0.92-1.06],0.707208917195288,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.01 [0.95-1.07],0.707235723876998,cis
Chapter VI Diseases of the nervous system,FALLS,SELENOP,Selenoprotein P,Inverse variance weighted,2,1.03 [0.89-1.18],0.710403013575921,cis
Chapter VI Diseases of the nervous system,FALLS,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1 [0.98-1.02],0.712253694067546,cis
Chapter VI Diseases of the nervous system,FALLS,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.01 [0.97-1.04],0.713381278668422,cis
Chapter VI Diseases of the nervous system,FALLS,SPON2,Spondin-2,Inverse variance weighted,4,1.01 [0.96-1.06],0.716591567772467,cis
Chapter VI Diseases of the nervous system,FALLS,MATN3,Matrilin-3,Inverse variance weighted,28,1 [0.97-1.02],0.716593528703232,cis
Chapter VI Diseases of the nervous system,FALLS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.98 [0.88-1.09],0.720055831381319,cis
Chapter VI Diseases of the nervous system,FALLS,OSM,Oncostatin-M,Wald ratio,1,1.03 [0.88-1.2],0.726240793105363,cis
Chapter VI Diseases of the nervous system,FALLS,EPO,Erythropoietin,Inverse variance weighted,5,1.02 [0.9-1.16],0.728134724782238,cis
Chapter VI Diseases of the nervous system,FALLS,PGF,Placenta growth factor,Inverse variance weighted,2,0.95 [0.72-1.25],0.728855236989998,cis
Chapter VI Diseases of the nervous system,FALLS,FBLN2,Fibulin-2,Inverse variance weighted,11,0.99 [0.96-1.03],0.729427322921162,cis
Chapter VI Diseases of the nervous system,FALLS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.98 [0.87-1.1],0.733514756141468,cis
Chapter VI Diseases of the nervous system,FALLS,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.03 [0.87-1.21],0.742615590428815,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.05 [0.79-1.39],0.74321001581826,cis
Chapter VI Diseases of the nervous system,FALLS,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.03 [0.87-1.22],0.745656702426666,cis
Chapter VI Diseases of the nervous system,FALLS,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1 [0.99-1.02],0.747229653528102,cis
Chapter VI Diseases of the nervous system,FALLS,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.02 [0.9-1.16],0.759657472174296,cis
Chapter VI Diseases of the nervous system,FALLS,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1 [0.99-1.01],0.761109405546133,cis
Chapter VI Diseases of the nervous system,FALLS,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.02 [0.92-1.12],0.765363260753163,cis
Chapter VI Diseases of the nervous system,FALLS,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1 [0.98-1.02],0.765403166280858,cis
Chapter VI Diseases of the nervous system,FALLS,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.01 [0.95-1.07],0.766645077328954,cis
Chapter VI Diseases of the nervous system,FALLS,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,10,0.99 [0.96-1.03],0.76695357471368,cis
Chapter VI Diseases of the nervous system,FALLS,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.01 [0.95-1.07],0.76711439027524,cis
Chapter VI Diseases of the nervous system,FALLS,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.01 [0.93-1.1],0.769297958694224,cis
Chapter VI Diseases of the nervous system,FALLS,CFD,Complement factor D,Inverse variance weighted,11,0.99 [0.96-1.03],0.769622854368847,cis
Chapter VI Diseases of the nervous system,FALLS,PSAP,Prosaposin,Inverse variance weighted,5,0.99 [0.95-1.04],0.775644503830924,cis
Chapter VI Diseases of the nervous system,FALLS,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.01 [0.96-1.05],0.777950397201345,cis
Chapter VI Diseases of the nervous system,FALLS,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1 [0.98-1.02],0.782546998464239,cis
Chapter VI Diseases of the nervous system,FALLS,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1 [0.97-1.02],0.783938484719652,cis
Chapter VI Diseases of the nervous system,FALLS,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.01 [0.94-1.08],0.793593811679229,cis
Chapter VI Diseases of the nervous system,FALLS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1 [0.98-1.03],0.794638702407459,cis
Chapter VI Diseases of the nervous system,FALLS,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.02 [0.89-1.16],0.798357906701088,cis
Chapter VI Diseases of the nervous system,FALLS,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1 [0.98-1.02],0.800120547222151,cis
Chapter VI Diseases of the nervous system,FALLS,SDC1,Syndecan-1,Inverse variance weighted,2,1.02 [0.87-1.21],0.801050421345588,cis
Chapter VI Diseases of the nervous system,FALLS,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.99 [0.94-1.05],0.802305036712132,cis
Chapter VI Diseases of the nervous system,FALLS,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1 [0.98-1.02],0.804175441387205,cis
Chapter VI Diseases of the nervous system,FALLS,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.02 [0.86-1.22],0.804564844138689,cis
Chapter VI Diseases of the nervous system,FALLS,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,0.99 [0.93-1.06],0.807142878844603,cis
Chapter VI Diseases of the nervous system,FALLS,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1 [0.98-1.02],0.807922014662038,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1 [0.98-1.03],0.809646712851174,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.01 [0.96-1.06],0.810399685813566,cis
Chapter VI Diseases of the nervous system,FALLS,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.01 [0.92-1.12],0.81262437024884,cis
Chapter VI Diseases of the nervous system,FALLS,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.99 [0.93-1.06],0.813324842840518,cis
Chapter VI Diseases of the nervous system,FALLS,PTN,Pleiotrophin,Inverse variance weighted,4,1.01 [0.92-1.11],0.823983946373074,cis
Chapter VI Diseases of the nervous system,FALLS,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.01 [0.92-1.12],0.82705010395459,cis
Chapter VI Diseases of the nervous system,FALLS,PVR,Poliovirus receptor,Inverse variance weighted,27,1 [0.99-1.02],0.827112741365466,cis
Chapter VI Diseases of the nervous system,FALLS,GSN,Gelsolin,Inverse variance weighted,5,1.01 [0.89-1.15],0.831792318744228,cis
Chapter VI Diseases of the nervous system,FALLS,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1 [0.96-1.03],0.836954472010305,cis
Chapter VI Diseases of the nervous system,FALLS,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,1 [0.97-1.03],0.837115783146571,cis
Chapter VI Diseases of the nervous system,FALLS,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,1 [0.95-1.04],0.839951627660096,cis
Chapter VI Diseases of the nervous system,FALLS,CTSD,Cathepsin D,Inverse variance weighted,17,1 [0.96-1.03],0.841160030979592,cis
Chapter VI Diseases of the nervous system,FALLS,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1 [0.96-1.05],0.841367358658037,cis
Chapter VI Diseases of the nervous system,FALLS,F3,Tissue factor,Inverse variance weighted,11,1 [0.95-1.05],0.843731019872963,cis
Chapter VI Diseases of the nervous system,FALLS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.01 [0.95-1.07],0.844019889217936,cis
Chapter VI Diseases of the nervous system,FALLS,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,1 [0.96-1.05],0.846997163246554,cis
Chapter VI Diseases of the nervous system,FALLS,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.01 [0.95-1.07],0.847741938297122,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.02 [0.86-1.2],0.84849426108582,cis
Chapter VI Diseases of the nervous system,FALLS,FAM3D,Protein FAM3D,Inverse variance weighted,17,1 [0.96-1.04],0.850367432228531,cis
Chapter VI Diseases of the nervous system,FALLS,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.99 [0.93-1.06],0.851337063563251,cis
Chapter VI Diseases of the nervous system,FALLS,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1 [0.98-1.03],0.852817249513804,cis
Chapter VI Diseases of the nervous system,FALLS,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.99 [0.85-1.15],0.856410581942185,cis
Chapter VI Diseases of the nervous system,FALLS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1 [0.97-1.03],0.85775656661515,cis
Chapter VI Diseases of the nervous system,FALLS,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1.01 [0.93-1.09],0.865034913871075,cis
Chapter VI Diseases of the nervous system,FALLS,CD27,CD27 antigen,Inverse variance weighted,9,1 [0.97-1.03],0.865448584773829,cis
Chapter VI Diseases of the nervous system,FALLS,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.03 [0.7-1.52],0.866141996454409,cis
Chapter VI Diseases of the nervous system,FALLS,SERPINA11,Serpin A11,Inverse variance weighted,31,1 [0.98-1.02],0.869670538011338,cis
Chapter VI Diseases of the nervous system,FALLS,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.99 [0.9-1.09],0.875414577650638,cis
Chapter VI Diseases of the nervous system,FALLS,BSG,Basigin,Wald ratio,1,1.01 [0.93-1.09],0.876459025672728,cis
Chapter VI Diseases of the nervous system,FALLS,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1 [0.98-1.01],0.876993633863273,cis
Chapter VI Diseases of the nervous system,FALLS,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.99 [0.9-1.1],0.882657550750755,cis
Chapter VI Diseases of the nervous system,FALLS,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,4,1 [0.95-1.05],0.889298293838299,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.01 [0.92-1.1],0.89166047228281,cis
Chapter VI Diseases of the nervous system,FALLS,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1.01 [0.9-1.12],0.892530188639571,cis
Chapter VI Diseases of the nervous system,FALLS,SPON1,Spondin-1,Inverse variance weighted,21,1 [0.98-1.03],0.899437791472038,cis
Chapter VI Diseases of the nervous system,FALLS,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,1 [0.98-1.02],0.899539072844904,cis
Chapter VI Diseases of the nervous system,FALLS,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,1 [0.96-1.05],0.904113349722349,cis
Chapter VI Diseases of the nervous system,FALLS,OCLN,Occludin,Inverse variance weighted,2,1.01 [0.88-1.15],0.905489669071269,cis
Chapter VI Diseases of the nervous system,FALLS,TFF2,Trefoil factor 2,Inverse variance weighted,5,1 [0.94-1.06],0.912773623110557,cis
Chapter VI Diseases of the nervous system,FALLS,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1 [0.96-1.04],0.916022198118927,cis
Chapter VI Diseases of the nervous system,FALLS,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1 [0.96-1.05],0.916031756460376,cis
Chapter VI Diseases of the nervous system,FALLS,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,1 [0.94-1.07],0.917403412551253,cis
Chapter VI Diseases of the nervous system,FALLS,CHGA,Chromogranin-A,Inverse variance weighted,3,1 [0.93-1.08],0.918907892933722,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1 [0.95-1.05],0.91972354984884,cis
Chapter VI Diseases of the nervous system,FALLS,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1 [0.95-1.05],0.921894037693857,cis
Chapter VI Diseases of the nervous system,FALLS,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1 [0.99-1.01],0.922131117464116,cis
Chapter VI Diseases of the nervous system,FALLS,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,6,1 [0.97-1.04],0.927905581911706,cis
Chapter VI Diseases of the nervous system,FALLS,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1 [0.97-1.04],0.928203528837591,cis
Chapter VI Diseases of the nervous system,FALLS,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1 [0.95-1.05],0.930266963850512,cis
Chapter VI Diseases of the nervous system,FALLS,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1 [0.92-1.08],0.931007171729171,cis
Chapter VI Diseases of the nervous system,FALLS,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1 [0.98-1.02],0.93473437891152,cis
Chapter VI Diseases of the nervous system,FALLS,UMOD,Uromodulin,Inverse variance weighted,29,1 [0.99-1.02],0.93693728278137,cis
Chapter VI Diseases of the nervous system,FALLS,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,1 [0.94-1.06],0.93911729021589,cis
Chapter VI Diseases of the nervous system,FALLS,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1 [0.89-1.12],0.942619496788495,cis
Chapter VI Diseases of the nervous system,FALLS,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1 [0.96-1.05],0.942644899961955,cis
Chapter VI Diseases of the nervous system,FALLS,TCL1A,T-cell leukemia/lymphoma protein 1A,Inverse variance weighted,11,1 [0.97-1.03],0.942728977473361,cis
Chapter VI Diseases of the nervous system,FALLS,SEPTIN8,Septin-8,Inverse variance weighted,2,1 [0.87-1.14],0.943390313027574,cis
Chapter VI Diseases of the nervous system,FALLS,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,1 [0.96-1.04],0.943629530208649,cis
Chapter VI Diseases of the nervous system,FALLS,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1 [0.96-1.04],0.946063342826056,cis
Chapter VI Diseases of the nervous system,FALLS,AGRN,Agrin,Inverse variance weighted,17,1 [0.97-1.03],0.946723682577593,cis
Chapter VI Diseases of the nervous system,FALLS,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.01 [0.83-1.22],0.949559829772505,cis
Chapter VI Diseases of the nervous system,FALLS,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,1 [0.98-1.02],0.95000003203092,cis
Chapter VI Diseases of the nervous system,FALLS,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1 [0.93-1.08],0.951678275764479,cis
Chapter VI Diseases of the nervous system,FALLS,SNCG,Gamma-synuclein,Inverse variance weighted,36,1 [0.98-1.02],0.951703442362758,cis
Chapter VI Diseases of the nervous system,FALLS,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1 [0.98-1.02],0.956530122809652,cis
Chapter VI Diseases of the nervous system,FALLS,MMP7,Matrilysin,Inverse variance weighted,13,1 [0.97-1.03],0.961916412136495,cis
Chapter VI Diseases of the nervous system,FALLS,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1 [0.98-1.02],0.966238633569021,cis
Chapter VI Diseases of the nervous system,FALLS,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1 [0.96-1.04],0.975491030514241,cis
Chapter VI Diseases of the nervous system,FALLS,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1 [0.97-1.03],0.977024256985684,cis
Chapter VI Diseases of the nervous system,FALLS,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1 [0.92-1.08],0.9814799633371,cis
Chapter VI Diseases of the nervous system,FALLS,ITGA2,Integrin alpha-2,Inverse variance weighted,31,1 [0.98-1.02],0.982672583656893,cis
Chapter VI Diseases of the nervous system,FALLS,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,1 [0.91-1.09],0.982841146866118,cis
Chapter VI Diseases of the nervous system,FALLS,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,1 [0.95-1.06],0.987484758646792,cis
Chapter VI Diseases of the nervous system,FALLS,TNC,Tenascin,Inverse variance weighted,12,1 [0.96-1.05],0.990777248057354,cis
Chapter VI Diseases of the nervous system,FALLS,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1 [0.96-1.04],0.99163346839126,cis
Chapter VI Diseases of the nervous system,FALLS,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,1 [0.85-1.18],0.993601685154703,cis
Chapter VI Diseases of the nervous system,FALLS,ADAMTSL4,ADAMTS-like protein 4,Inverse variance weighted,12,1 [0.97-1.04],0.994817641884301,cis
Chapter VI Diseases of the nervous system,FALLS,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.23 [1.1-1.37],0.000275662947583878,trans
Chapter VI Diseases of the nervous system,FALLS,LGALS4,Galectin-4,Inverse variance weighted,15,0.96 [0.93-0.98],0.00104048859753345,trans
Chapter VI Diseases of the nervous system,FALLS,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.24 [1.09-1.41],0.00136798564677048,trans
Chapter VI Diseases of the nervous system,FALLS,SELENOP,Selenoprotein P,Inverse variance weighted,3,0.77 [0.66-0.91],0.00144232867753406,trans
Chapter VI Diseases of the nervous system,FALLS,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.92 [0.87-0.97],0.00188983886720506,trans
Chapter VI Diseases of the nervous system,FALLS,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.08 [1.03-1.13],0.00271665547228324,trans
Chapter VI Diseases of the nervous system,FALLS,LAYN,Layilin,Inverse variance weighted,3,1.25 [1.08-1.45],0.00294307996654077,trans
Chapter VI Diseases of the nervous system,FALLS,GHR,Growth hormone receptor,Inverse variance weighted,26,1.06 [1.02-1.11],0.0040350892844257,trans
Chapter VI Diseases of the nervous system,FALLS,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.14 [1.04-1.25],0.00493064421386044,trans
Chapter VI Diseases of the nervous system,FALLS,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.04 [1.01-1.07],0.00653661312233581,trans
Chapter VI Diseases of the nervous system,FALLS,KLK11,Kallikrein-11,Inverse variance weighted,13,0.92 [0.87-0.98],0.00824156580624886,trans
Chapter VI Diseases of the nervous system,FALLS,CSTB,Cystatin-B,Inverse variance weighted,23,1.04 [1.01-1.07],0.010267467560246,trans
Chapter VI Diseases of the nervous system,FALLS,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.78 [0.63-0.95],0.0125510706135124,trans
Chapter VI Diseases of the nervous system,FALLS,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,0.9 [0.83-0.98],0.0128657718162765,trans
Chapter VI Diseases of the nervous system,FALLS,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.07 [1.01-1.14],0.01764808266723,trans
Chapter VI Diseases of the nervous system,FALLS,POF1B,Protein POF1B,Inverse variance weighted,4,1.14 [1.02-1.27],0.0180706062912916,trans
Chapter VI Diseases of the nervous system,FALLS,RSPO1,R-spondin-1,Inverse variance weighted,8,1.08 [1.01-1.14],0.0187885363808205,trans
Chapter VI Diseases of the nervous system,FALLS,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.05 [1.01-1.1],0.0217953210013346,trans
Chapter VI Diseases of the nervous system,FALLS,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.07 [1.01-1.13],0.022483667835041,trans
Chapter VI Diseases of the nervous system,FALLS,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.14 [1.02-1.28],0.0236705381924458,trans
Chapter VI Diseases of the nervous system,FALLS,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,0.92 [0.86-0.99],0.0253111578212821,trans
Chapter VI Diseases of the nervous system,FALLS,LGALS9,Galectin-9,Inverse variance weighted,36,0.98 [0.95-1],0.0253549022676822,trans
Chapter VI Diseases of the nervous system,FALLS,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.92 [0.85-0.99],0.0282966612097577,trans
Chapter VI Diseases of the nervous system,FALLS,GRN,Progranulin,Inverse variance weighted,46,0.98 [0.96-1],0.0353513862551946,trans
Chapter VI Diseases of the nervous system,FALLS,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.06 [1-1.13],0.0358450695008546,trans
Chapter VI Diseases of the nervous system,FALLS,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,6,1.09 [1.01-1.18],0.0363426970633752,trans
Chapter VI Diseases of the nervous system,FALLS,MUC13,Mucin-13,Inverse variance weighted,3,0.84 [0.71-0.99],0.0368544188137889,trans
Chapter VI Diseases of the nervous system,FALLS,NECTIN4,Nectin-4,Inverse variance weighted,4,1.14 [1.01-1.29],0.039731571260495,trans
Chapter VI Diseases of the nervous system,FALLS,DSC2,Desmocollin-2,Inverse variance weighted,16,1.04 [1-1.07],0.0484720538543178,trans
Chapter VI Diseases of the nervous system,FALLS,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.91 [0.82-1],0.0489543221779829,trans
Chapter VI Diseases of the nervous system,FALLS,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,1.04 [1-1.08],0.0596766557609679,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.14 [0.99-1.3],0.0609893096624885,trans
Chapter VI Diseases of the nervous system,FALLS,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.84 [0.7-1.01],0.0630678502142807,trans
Chapter VI Diseases of the nervous system,FALLS,CDH1,Cadherin-1,Inverse variance weighted,16,1.03 [1-1.07],0.0682169118510248,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.86 [0.73-1.01],0.0743020983564532,trans
Chapter VI Diseases of the nervous system,FALLS,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.06 [0.99-1.14],0.0746009514583863,trans
Chapter VI Diseases of the nervous system,FALLS,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,1.23 [0.98-1.54],0.075345281583689,trans
Chapter VI Diseases of the nervous system,FALLS,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.09 [0.99-1.19],0.0769404377941058,trans
Chapter VI Diseases of the nervous system,FALLS,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.94 [0.87-1.01],0.0781174349987487,trans
Chapter VI Diseases of the nervous system,FALLS,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.05 [0.99-1.1],0.0785349765423245,trans
Chapter VI Diseases of the nervous system,FALLS,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.16 [0.98-1.37],0.079926951155156,trans
Chapter VI Diseases of the nervous system,FALLS,PALM2,Paralemmin-2,Inverse variance weighted,9,1.04 [1-1.09],0.0800689057508353,trans
Chapter VI Diseases of the nervous system,FALLS,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.37 [0.96-1.94],0.0808976708957694,trans
Chapter VI Diseases of the nervous system,FALLS,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.05 [0.99-1.12],0.0838706680455453,trans
Chapter VI Diseases of the nervous system,FALLS,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.89 [0.78-1.02],0.0851071387965364,trans
Chapter VI Diseases of the nervous system,FALLS,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.05 [0.99-1.1],0.0867867279553044,trans
Chapter VI Diseases of the nervous system,FALLS,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,0.78 [0.59-1.04],0.0884263239232282,trans
Chapter VI Diseases of the nervous system,FALLS,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.02 [1-1.03],0.0890667337028054,trans
Chapter VI Diseases of the nervous system,FALLS,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.95 [0.9-1.01],0.090056662321226,trans
Chapter VI Diseases of the nervous system,FALLS,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.06 [0.99-1.13],0.0913262208760736,trans
Chapter VI Diseases of the nervous system,FALLS,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,0.96 [0.93-1.01],0.0933711888400522,trans
Chapter VI Diseases of the nervous system,FALLS,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.94 [0.87-1.01],0.0940716293638329,trans
Chapter VI Diseases of the nervous system,FALLS,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.86 [0.72-1.03],0.0967938243237573,trans
Chapter VI Diseases of the nervous system,FALLS,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.94 [0.88-1.01],0.100335525291365,trans
Chapter VI Diseases of the nervous system,FALLS,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.95 [0.9-1.01],0.102583847867631,trans
Chapter VI Diseases of the nervous system,FALLS,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.95 [0.9-1.01],0.105454684633281,trans
Chapter VI Diseases of the nervous system,FALLS,AGRN,Agrin,Inverse variance weighted,14,0.95 [0.9-1.01],0.105593416989412,trans
Chapter VI Diseases of the nervous system,FALLS,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.05 [0.99-1.12],0.107535343099627,trans
Chapter VI Diseases of the nervous system,FALLS,WNT9A,Protein Wnt-9a,Wald ratio,1,0.78 [0.58-1.06],0.109433042989658,trans
Chapter VI Diseases of the nervous system,FALLS,ITGA11,Integrin alpha-11,Inverse variance weighted,7,1.09 [0.98-1.22],0.109720526747502,trans
Chapter VI Diseases of the nervous system,FALLS,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.06 [0.99-1.13],0.109895870576632,trans
Chapter VI Diseases of the nervous system,FALLS,UMOD,Uromodulin,Inverse variance weighted,34,0.97 [0.94-1.01],0.111102123425363,trans
Chapter VI Diseases of the nervous system,FALLS,NECTIN2,Nectin-2,Inverse variance weighted,3,1.19 [0.96-1.48],0.113149248620849,trans
Chapter VI Diseases of the nervous system,FALLS,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.95 [0.89-1.01],0.114859967035305,trans
Chapter VI Diseases of the nervous system,FALLS,CD99,CD99 antigen,Inverse variance weighted,4,0.93 [0.85-1.02],0.116702557508164,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.98 [0.96-1],0.117638506582362,trans
Chapter VI Diseases of the nervous system,FALLS,CFP,Properdin,Inverse variance weighted,17,1.04 [0.99-1.09],0.123555638281689,trans
Chapter VI Diseases of the nervous system,FALLS,OGN,Mimecan,Inverse variance weighted,37,0.98 [0.96-1],0.124829814494508,trans
Chapter VI Diseases of the nervous system,FALLS,IL32,Interleukin-32,Inverse variance weighted,9,1.07 [0.98-1.16],0.126473261935555,trans
Chapter VI Diseases of the nervous system,FALLS,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,1.06 [0.98-1.14],0.127619745053853,trans
Chapter VI Diseases of the nervous system,FALLS,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.08 [0.98-1.19],0.132366286113043,trans
Chapter VI Diseases of the nervous system,FALLS,OCLN,Occludin,Inverse variance weighted,2,1.12 [0.96-1.3],0.136972778798652,trans
Chapter VI Diseases of the nervous system,FALLS,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,1.05 [0.98-1.13],0.137786685004771,trans
Chapter VI Diseases of the nervous system,FALLS,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,1.06 [0.98-1.13],0.142066375225606,trans
Chapter VI Diseases of the nervous system,FALLS,CBLN4,Cerebellin-4,Inverse variance weighted,17,0.97 [0.93-1.01],0.145322156365879,trans
Chapter VI Diseases of the nervous system,FALLS,SDC1,Syndecan-1,Inverse variance weighted,12,0.96 [0.91-1.01],0.145696924542765,trans
Chapter VI Diseases of the nervous system,FALLS,MMP7,Matrilysin,Wald ratio,1,0.93 [0.84-1.03],0.146163473836811,trans
Chapter VI Diseases of the nervous system,FALLS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.04 [0.99-1.1],0.147952363048414,trans
Chapter VI Diseases of the nervous system,FALLS,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.93 [0.84-1.03],0.152115048360522,trans
Chapter VI Diseases of the nervous system,FALLS,ITGA2,Integrin alpha-2,Inverse variance weighted,13,1.07 [0.98-1.16],0.155985856597879,trans
Chapter VI Diseases of the nervous system,FALLS,PRSS8,Prostasin,Inverse variance weighted,14,0.96 [0.92-1.01],0.157119950069526,trans
Chapter VI Diseases of the nervous system,FALLS,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.13 [0.95-1.35],0.157347323323775,trans
Chapter VI Diseases of the nervous system,FALLS,ELN,Elastin,Inverse variance weighted,10,1.05 [0.98-1.13],0.161295281228978,trans
Chapter VI Diseases of the nervous system,FALLS,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.04 [0.98-1.1],0.16201289801065,trans
Chapter VI Diseases of the nervous system,FALLS,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.89 [0.76-1.05],0.162482721554983,trans
Chapter VI Diseases of the nervous system,FALLS,NRP1,Neuropilin-1,Inverse variance weighted,14,1.05 [0.98-1.12],0.167812798121286,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.85 [0.68-1.07],0.173360777099738,trans
Chapter VI Diseases of the nervous system,FALLS,RETN,Resistin,Inverse variance weighted,19,0.97 [0.93-1.01],0.176805384664345,trans
Chapter VI Diseases of the nervous system,FALLS,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.09 [0.96-1.23],0.179835576555114,trans
Chapter VI Diseases of the nervous system,FALLS,ITGAM,Integrin alpha-M,Inverse variance weighted,12,1.06 [0.97-1.15],0.181150018247971,trans
Chapter VI Diseases of the nervous system,FALLS,CD27,CD27 antigen,Inverse variance weighted,9,0.94 [0.86-1.03],0.181884284433331,trans
Chapter VI Diseases of the nervous system,FALLS,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.05 [0.98-1.13],0.186214170409605,trans
Chapter VI Diseases of the nervous system,FALLS,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.04 [0.98-1.12],0.187325154713743,trans
Chapter VI Diseases of the nervous system,FALLS,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.06 [0.97-1.16],0.187655292436619,trans
Chapter VI Diseases of the nervous system,FALLS,MYL3,Myosin light chain 3,Inverse variance weighted,13,0.95 [0.87-1.03],0.188084942630004,trans
Chapter VI Diseases of the nervous system,FALLS,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.04 [0.98-1.11],0.188090024522303,trans
Chapter VI Diseases of the nervous system,FALLS,SPON2,Spondin-2,Inverse variance weighted,3,1.1 [0.95-1.27],0.192438900541003,trans
Chapter VI Diseases of the nervous system,FALLS,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.92 [0.81-1.04],0.192524309740556,trans
Chapter VI Diseases of the nervous system,FALLS,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,0.98 [0.94-1.01],0.194239408562297,trans
Chapter VI Diseases of the nervous system,FALLS,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,1.02 [0.99-1.04],0.194790891142205,trans
Chapter VI Diseases of the nervous system,FALLS,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.93 [0.82-1.04],0.197685684681183,trans
Chapter VI Diseases of the nervous system,FALLS,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,1.01 [0.99-1.04],0.19786150364557,trans
Chapter VI Diseases of the nervous system,FALLS,CD302,CD302 antigen,Inverse variance weighted,11,1.03 [0.98-1.09],0.199840853966635,trans
Chapter VI Diseases of the nervous system,FALLS,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.97 [0.92-1.02],0.200925726810854,trans
Chapter VI Diseases of the nervous system,FALLS,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.97 [0.93-1.02],0.202728031657994,trans
Chapter VI Diseases of the nervous system,FALLS,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,1.04 [0.98-1.11],0.205582471113907,trans
Chapter VI Diseases of the nervous system,FALLS,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.21 [0.9-1.62],0.205596037003096,trans
Chapter VI Diseases of the nervous system,FALLS,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,0.99 [0.98-1],0.207271241842327,trans
Chapter VI Diseases of the nervous system,FALLS,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.03 [0.98-1.09],0.20932986677666,trans
Chapter VI Diseases of the nervous system,FALLS,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.96 [0.91-1.02],0.210875161821493,trans
Chapter VI Diseases of the nervous system,FALLS,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.1 [0.95-1.27],0.216930504094143,trans
Chapter VI Diseases of the nervous system,FALLS,FAM3D,Protein FAM3D,Inverse variance weighted,38,1.01 [0.99-1.04],0.217442899471654,trans
Chapter VI Diseases of the nervous system,FALLS,C7,Complement component C7,Inverse variance weighted,26,1.01 [0.99-1.04],0.219898314891764,trans
Chapter VI Diseases of the nervous system,FALLS,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,0.97 [0.93-1.02],0.222301499101568,trans
Chapter VI Diseases of the nervous system,FALLS,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.96 [0.89-1.03],0.22532809015714,trans
Chapter VI Diseases of the nervous system,FALLS,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,0.96 [0.9-1.03],0.229985168565301,trans
Chapter VI Diseases of the nervous system,FALLS,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,0.98 [0.94-1.01],0.230407432384049,trans
Chapter VI Diseases of the nervous system,FALLS,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,7,1.03 [0.98-1.09],0.232117890607882,trans
Chapter VI Diseases of the nervous system,FALLS,CHAD,Chondroadherin,Inverse variance weighted,15,1.03 [0.98-1.07],0.234277548941435,trans
Chapter VI Diseases of the nervous system,FALLS,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,7,1.08 [0.95-1.23],0.235224268018126,trans
Chapter VI Diseases of the nervous system,FALLS,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1.02 [0.99-1.05],0.241659250858204,trans
Chapter VI Diseases of the nervous system,FALLS,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.92 [0.79-1.06],0.241903297928463,trans
Chapter VI Diseases of the nervous system,FALLS,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.02 [0.98-1.06],0.247747357320286,trans
Chapter VI Diseases of the nervous system,FALLS,MATN3,Matrilin-3,Inverse variance weighted,4,0.96 [0.89-1.03],0.249763441816892,trans
Chapter VI Diseases of the nervous system,FALLS,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.95 [0.88-1.04],0.251430955006788,trans
Chapter VI Diseases of the nervous system,FALLS,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.92 [0.8-1.06],0.252494027889227,trans
Chapter VI Diseases of the nervous system,FALLS,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,11,0.97 [0.93-1.02],0.252535033290965,trans
Chapter VI Diseases of the nervous system,FALLS,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.98 [0.95-1.01],0.253303642868389,trans
Chapter VI Diseases of the nervous system,FALLS,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,1.06 [0.96-1.16],0.255333485688937,trans
Chapter VI Diseases of the nervous system,FALLS,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.1 [0.93-1.29],0.256423717984227,trans
Chapter VI Diseases of the nervous system,FALLS,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.96 [0.89-1.03],0.258037320569049,trans
Chapter VI Diseases of the nervous system,FALLS,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.04 [0.97-1.1],0.260528713017556,trans
Chapter VI Diseases of the nervous system,FALLS,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.03 [0.98-1.09],0.263918047261121,trans
Chapter VI Diseases of the nervous system,FALLS,IL19,Interleukin-19,Inverse variance weighted,10,0.98 [0.95-1.01],0.263926273324738,trans
Chapter VI Diseases of the nervous system,FALLS,SLAMF8,SLAM family member 8,Inverse variance weighted,2,1.09 [0.94-1.27],0.264121941020539,trans
Chapter VI Diseases of the nervous system,FALLS,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.02 [0.99-1.05],0.265384413780539,trans
Chapter VI Diseases of the nervous system,FALLS,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.99 [0.96-1.01],0.266853237301391,trans
Chapter VI Diseases of the nervous system,FALLS,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.08 [0.94-1.25],0.269713856382628,trans
Chapter VI Diseases of the nervous system,FALLS,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.92 [0.8-1.06],0.271008685421718,trans
Chapter VI Diseases of the nervous system,FALLS,ADIPOQ,Adiponectin,Inverse variance weighted,25,1.02 [0.99-1.05],0.273800088887936,trans
Chapter VI Diseases of the nervous system,FALLS,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.03 [0.98-1.08],0.281053983713175,trans
Chapter VI Diseases of the nervous system,FALLS,MSTN,Growth/differentiation factor 8,Inverse variance weighted,11,0.94 [0.85-1.05],0.282173873819505,trans
Chapter VI Diseases of the nervous system,FALLS,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.04 [0.97-1.13],0.2866830052057,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.07 [0.95-1.2],0.287725244396186,trans
Chapter VI Diseases of the nervous system,FALLS,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,17,1.03 [0.97-1.09],0.290724152918869,trans
Chapter VI Diseases of the nervous system,FALLS,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.88 [0.69-1.12],0.294813191477719,trans
Chapter VI Diseases of the nervous system,FALLS,KLK4,Kallikrein-4,Inverse variance weighted,5,0.93 [0.81-1.06],0.295494618036269,trans
Chapter VI Diseases of the nervous system,FALLS,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,0.96 [0.88-1.04],0.298325509959888,trans
Chapter VI Diseases of the nervous system,FALLS,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,0.98 [0.95-1.02],0.302378644589516,trans
Chapter VI Diseases of the nervous system,FALLS,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.99 [0.97-1.01],0.303455413047124,trans
Chapter VI Diseases of the nervous system,FALLS,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.07 [0.94-1.22],0.307583836671707,trans
Chapter VI Diseases of the nervous system,FALLS,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.04 [0.97-1.12],0.307664324648612,trans
Chapter VI Diseases of the nervous system,FALLS,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.91 [0.76-1.09],0.311571939436763,trans
Chapter VI Diseases of the nervous system,FALLS,CHGB,Secretogranin-1,Inverse variance weighted,7,1.05 [0.96-1.14],0.315834086454234,trans
Chapter VI Diseases of the nervous system,FALLS,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,1.02 [0.99-1.05],0.319615003063201,trans
Chapter VI Diseases of the nervous system,FALLS,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,21,1.04 [0.96-1.12],0.32211080007663,trans
Chapter VI Diseases of the nervous system,FALLS,FBLN2,Fibulin-2,Inverse variance weighted,6,1.04 [0.96-1.14],0.326954068581222,trans
Chapter VI Diseases of the nervous system,FALLS,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.07 [0.94-1.21],0.327707189773827,trans
Chapter VI Diseases of the nervous system,FALLS,CCN3,CCN family member 3,Inverse variance weighted,17,1.02 [0.98-1.05],0.32998446222156,trans
Chapter VI Diseases of the nervous system,FALLS,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,1.07 [0.93-1.22],0.334474507871861,trans
Chapter VI Diseases of the nervous system,FALLS,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.02 [0.98-1.06],0.338233270414764,trans
Chapter VI Diseases of the nervous system,FALLS,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,0.91 [0.76-1.1],0.338689031016536,trans
Chapter VI Diseases of the nervous system,FALLS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.06 [0.94-1.21],0.342019042346697,trans
Chapter VI Diseases of the nervous system,FALLS,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,23,1.01 [0.99-1.04],0.342292954051338,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.98 [0.95-1.02],0.342771662630867,trans
Chapter VI Diseases of the nervous system,FALLS,MMP3,Stromelysin-1,Inverse variance weighted,4,0.93 [0.79-1.09],0.351929148261211,trans
Chapter VI Diseases of the nervous system,FALLS,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,0.94 [0.82-1.08],0.351963245381396,trans
Chapter VI Diseases of the nervous system,FALLS,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.92 [0.77-1.1],0.3554513917676,trans
Chapter VI Diseases of the nervous system,FALLS,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.1 [0.9-1.35],0.358374593437314,trans
Chapter VI Diseases of the nervous system,FALLS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.04 [0.96-1.12],0.361744825534518,trans
Chapter VI Diseases of the nervous system,FALLS,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.99 [0.96-1.01],0.365704014531425,trans
Chapter VI Diseases of the nervous system,FALLS,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.99 [0.96-1.02],0.368979328707352,trans
Chapter VI Diseases of the nervous system,FALLS,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,1.04 [0.96-1.13],0.36899824662501,trans
Chapter VI Diseases of the nervous system,FALLS,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.05 [0.95-1.16],0.371697219192256,trans
Chapter VI Diseases of the nervous system,FALLS,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.96 [0.88-1.05],0.376061335617574,trans
Chapter VI Diseases of the nervous system,FALLS,GDF15,Growth/differentiation factor 15,Wald ratio,1,1.15 [0.84-1.58],0.376793504442664,trans
Chapter VI Diseases of the nervous system,FALLS,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1.01 [0.99-1.04],0.380213689735376,trans
Chapter VI Diseases of the nervous system,FALLS,CLEC3B,Tetranectin,Inverse variance weighted,2,0.92 [0.76-1.11],0.382938810413646,trans
Chapter VI Diseases of the nervous system,FALLS,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.04 [0.95-1.14],0.38547431822395,trans
Chapter VI Diseases of the nervous system,FALLS,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.03 [0.96-1.11],0.388514256772598,trans
Chapter VI Diseases of the nervous system,FALLS,SLAMF7,SLAM family member 7,Inverse variance weighted,16,0.97 [0.92-1.03],0.388558914777238,trans
Chapter VI Diseases of the nervous system,FALLS,CX3CL1,Fractalkine,Inverse variance weighted,12,1.03 [0.96-1.11],0.391243311331143,trans
Chapter VI Diseases of the nervous system,FALLS,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.94 [0.81-1.09],0.392962986205423,trans
Chapter VI Diseases of the nervous system,FALLS,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.99 [0.98-1.01],0.393252836313283,trans
Chapter VI Diseases of the nervous system,FALLS,OSM,Oncostatin-M,Inverse variance weighted,6,0.97 [0.9-1.04],0.395957993826734,trans
Chapter VI Diseases of the nervous system,FALLS,CAPG,Macrophage-capping protein,Wald ratio,1,1.09 [0.89-1.33],0.39858994763016,trans
Chapter VI Diseases of the nervous system,FALLS,VCAN,Versican core protein,Inverse variance weighted,30,1.02 [0.97-1.08],0.400259498051744,trans
Chapter VI Diseases of the nervous system,FALLS,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.95 [0.85-1.07],0.408008067762842,trans
Chapter VI Diseases of the nervous system,FALLS,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.04 [0.95-1.12],0.411012466211519,trans
Chapter VI Diseases of the nervous system,FALLS,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.03 [0.96-1.1],0.413487329761499,trans
Chapter VI Diseases of the nervous system,FALLS,ADAMTSL4,ADAMTS-like protein 4,Inverse variance weighted,6,1.03 [0.96-1.11],0.415338462641239,trans
Chapter VI Diseases of the nervous system,FALLS,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.04 [0.94-1.16],0.42028092629855,trans
Chapter VI Diseases of the nervous system,FALLS,SERPINA11,Serpin A11,Inverse variance weighted,14,0.95 [0.85-1.07],0.420846816996147,trans
Chapter VI Diseases of the nervous system,FALLS,IMMT,MICOS complex subunit MIC60,Wald ratio,1,1.08 [0.9-1.29],0.426709867191394,trans
Chapter VI Diseases of the nervous system,FALLS,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.97 [0.9-1.05],0.427710190230051,trans
Chapter VI Diseases of the nervous system,FALLS,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,0.98 [0.93-1.03],0.431130826405423,trans
Chapter VI Diseases of the nervous system,FALLS,SPON1,Spondin-1,Inverse variance weighted,4,1.05 [0.93-1.18],0.431166696250028,trans
Chapter VI Diseases of the nervous system,FALLS,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.01 [0.98-1.05],0.432333684090788,trans
Chapter VI Diseases of the nervous system,FALLS,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.04 [0.95-1.13],0.439759654408779,trans
Chapter VI Diseases of the nervous system,FALLS,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.93 [0.79-1.11],0.449550119799183,trans
Chapter VI Diseases of the nervous system,FALLS,MDK,Midkine,Inverse variance weighted,14,1.04 [0.94-1.14],0.44974084318505,trans
Chapter VI Diseases of the nervous system,FALLS,IL15,Interleukin-15,Inverse variance weighted,35,1.01 [0.98-1.05],0.450540814256314,trans
Chapter VI Diseases of the nervous system,FALLS,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.02 [0.96-1.09],0.453620125460336,trans
Chapter VI Diseases of the nervous system,FALLS,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,19,1.02 [0.97-1.08],0.453641762792566,trans
Chapter VI Diseases of the nervous system,FALLS,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.84 [0.53-1.33],0.454025973248295,trans
Chapter VI Diseases of the nervous system,FALLS,PI3,Elafin,Inverse variance weighted,18,0.99 [0.96-1.02],0.454561520254251,trans
Chapter VI Diseases of the nervous system,FALLS,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,1.01 [0.98-1.04],0.456933333337624,trans
Chapter VI Diseases of the nervous system,FALLS,CTSL,Cathepsin L1,Inverse variance weighted,29,1.02 [0.97-1.06],0.459026054224938,trans
Chapter VI Diseases of the nervous system,FALLS,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.96 [0.87-1.06],0.46025476314724,trans
Chapter VI Diseases of the nervous system,FALLS,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,38,1.01 [0.98-1.05],0.460710131151127,trans
Chapter VI Diseases of the nervous system,FALLS,IFNL1,Interferon lambda-1,Inverse variance weighted,8,1.03 [0.96-1.1],0.461787955100286,trans
Chapter VI Diseases of the nervous system,FALLS,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.99 [0.97-1.01],0.464135250694593,trans
Chapter VI Diseases of the nervous system,FALLS,EPO,Erythropoietin,Inverse variance weighted,11,0.98 [0.92-1.04],0.464474670683639,trans
Chapter VI Diseases of the nervous system,FALLS,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.02 [0.97-1.07],0.464508947344536,trans
Chapter VI Diseases of the nervous system,FALLS,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.02 [0.97-1.07],0.466700049296431,trans
Chapter VI Diseases of the nervous system,FALLS,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.97 [0.89-1.05],0.466982282626353,trans
Chapter VI Diseases of the nervous system,FALLS,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.02 [0.96-1.09],0.469040939237317,trans
Chapter VI Diseases of the nervous system,FALLS,IL6,Interleukin-6,Inverse variance weighted,6,0.97 [0.91-1.04],0.47172041969576,trans
Chapter VI Diseases of the nervous system,FALLS,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,0.99 [0.95-1.02],0.478227405187667,trans
Chapter VI Diseases of the nervous system,FALLS,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.07 [0.89-1.29],0.479722870077361,trans
Chapter VI Diseases of the nervous system,FALLS,CNTN5,Contactin-5,Inverse variance weighted,22,1.02 [0.97-1.06],0.482050537152405,trans
Chapter VI Diseases of the nervous system,FALLS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.03 [0.95-1.11],0.484003297891481,trans
Chapter VI Diseases of the nervous system,FALLS,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.01 [0.99-1.03],0.485101833551923,trans
Chapter VI Diseases of the nervous system,FALLS,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.02 [0.97-1.07],0.485412538671281,trans
Chapter VI Diseases of the nervous system,FALLS,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.96 [0.86-1.07],0.485475536596678,trans
Chapter VI Diseases of the nervous system,FALLS,AFM,Afamin,Inverse variance weighted,8,0.97 [0.9-1.05],0.485710647196606,trans
Chapter VI Diseases of the nervous system,FALLS,GSN,Gelsolin,Inverse variance weighted,7,1.04 [0.94-1.14],0.487114735540461,trans
Chapter VI Diseases of the nervous system,FALLS,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.08 [0.87-1.34],0.49039719367193,trans
Chapter VI Diseases of the nervous system,FALLS,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,5,1.06 [0.89-1.26],0.495719214603117,trans
Chapter VI Diseases of the nervous system,FALLS,CTSV,Cathepsin L2,Inverse variance weighted,34,0.99 [0.96-1.02],0.497712343954959,trans
Chapter VI Diseases of the nervous system,FALLS,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,14,1.02 [0.97-1.07],0.501460702058621,trans
Chapter VI Diseases of the nervous system,FALLS,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.98 [0.93-1.03],0.502979994360679,trans
Chapter VI Diseases of the nervous system,FALLS,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,0.98 [0.93-1.04],0.507614557231562,trans
Chapter VI Diseases of the nervous system,FALLS,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,0.91 [0.7-1.2],0.510058640096285,trans
Chapter VI Diseases of the nervous system,FALLS,GUCA2A,Guanylin,Inverse variance weighted,7,0.97 [0.88-1.06],0.510403478858362,trans
Chapter VI Diseases of the nervous system,FALLS,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,0.91 [0.68-1.21],0.510459700966495,trans
Chapter VI Diseases of the nervous system,FALLS,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,0.94 [0.77-1.14],0.51431165921078,trans
Chapter VI Diseases of the nervous system,FALLS,IL17C,Interleukin-17C,Inverse variance weighted,5,1.04 [0.92-1.18],0.514727790173566,trans
Chapter VI Diseases of the nervous system,FALLS,BRK1,Protein BRICK1,Inverse variance weighted,10,0.98 [0.94-1.03],0.517784991706675,trans
Chapter VI Diseases of the nervous system,FALLS,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.97 [0.87-1.07],0.518286053619276,trans
Chapter VI Diseases of the nervous system,FALLS,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.03 [0.95-1.11],0.518690533040518,trans
Chapter VI Diseases of the nervous system,FALLS,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.95 [0.8-1.12],0.52303371941279,trans
Chapter VI Diseases of the nervous system,FALLS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.97 [0.89-1.06],0.524551837265073,trans
Chapter VI Diseases of the nervous system,FALLS,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.04 [0.91-1.2],0.525388645531898,trans
Chapter VI Diseases of the nervous system,FALLS,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.93 [0.74-1.16],0.533389512318887,trans
Chapter VI Diseases of the nervous system,FALLS,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.98 [0.93-1.04],0.533529079065055,trans
Chapter VI Diseases of the nervous system,FALLS,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.99 [0.95-1.03],0.533604420613169,trans
Chapter VI Diseases of the nervous system,FALLS,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.97 [0.88-1.07],0.538071206052387,trans
Chapter VI Diseases of the nervous system,FALLS,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.98 [0.92-1.04],0.540044752642455,trans
Chapter VI Diseases of the nervous system,FALLS,MSLN,Mesothelin,Inverse variance weighted,11,1.03 [0.94-1.13],0.541874486682255,trans
Chapter VI Diseases of the nervous system,FALLS,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.01 [0.97-1.06],0.542738349943444,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.96 [0.85-1.09],0.544252306712284,trans
Chapter VI Diseases of the nervous system,FALLS,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.95 [0.81-1.12],0.559857041635335,trans
Chapter VI Diseases of the nervous system,FALLS,SPP1,Osteopontin,Inverse variance weighted,13,0.97 [0.87-1.08],0.559881633550144,trans
Chapter VI Diseases of the nervous system,FALLS,SEPTIN8,Septin-8,Inverse variance weighted,4,0.97 [0.86-1.08],0.560266828329109,trans
Chapter VI Diseases of the nervous system,FALLS,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,1.03 [0.93-1.13],0.560946068838152,trans
Chapter VI Diseases of the nervous system,FALLS,BCAN,Brevican core protein,Inverse variance weighted,12,1.02 [0.95-1.09],0.561954400826734,trans
Chapter VI Diseases of the nervous system,FALLS,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.97 [0.88-1.07],0.566050772721548,trans
Chapter VI Diseases of the nervous system,FALLS,TCL1A,T-cell leukemia/lymphoma protein 1A,Inverse variance weighted,31,1.01 [0.97-1.05],0.569480045006463,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.04 [0.9-1.21],0.573571940821122,trans
Chapter VI Diseases of the nervous system,FALLS,ACTN2,Alpha-actinin-2,Inverse variance weighted,4,0.93 [0.73-1.19],0.574104111320917,trans
Chapter VI Diseases of the nervous system,FALLS,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,1.01 [0.97-1.05],0.574666490329308,trans
Chapter VI Diseases of the nervous system,FALLS,PSAP,Prosaposin,Inverse variance weighted,13,0.99 [0.96-1.03],0.574774186445287,trans
Chapter VI Diseases of the nervous system,FALLS,CD83,CD83 antigen,Inverse variance weighted,14,1.02 [0.95-1.1],0.576507137195046,trans
Chapter VI Diseases of the nervous system,FALLS,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.01 [0.99-1.02],0.579860758096384,trans
Chapter VI Diseases of the nervous system,FALLS,MILR1,Allergin-1,Inverse variance weighted,43,1 [0.98-1.01],0.579929227902286,trans
Chapter VI Diseases of the nervous system,FALLS,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.03 [0.93-1.14],0.580168885077036,trans
Chapter VI Diseases of the nervous system,FALLS,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,0.98 [0.93-1.04],0.582763184552782,trans
Chapter VI Diseases of the nervous system,FALLS,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.01 [0.96-1.07],0.58355667545647,trans
Chapter VI Diseases of the nervous system,FALLS,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,1.02 [0.96-1.08],0.583773166922129,trans
Chapter VI Diseases of the nervous system,FALLS,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,0.98 [0.92-1.04],0.584192562325667,trans
Chapter VI Diseases of the nervous system,FALLS,PENK,Proenkephalin-A,Inverse variance weighted,15,1.01 [0.97-1.06],0.585269054138579,trans
Chapter VI Diseases of the nervous system,FALLS,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.97 [0.88-1.08],0.587537595156316,trans
Chapter VI Diseases of the nervous system,FALLS,REN,Renin,Inverse variance weighted,8,0.96 [0.84-1.11],0.590466666423575,trans
Chapter VI Diseases of the nervous system,FALLS,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.98 [0.91-1.06],0.590918970891887,trans
Chapter VI Diseases of the nervous system,FALLS,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.98 [0.9-1.06],0.592646670250648,trans
Chapter VI Diseases of the nervous system,FALLS,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.98 [0.89-1.07],0.598947321440773,trans
Chapter VI Diseases of the nervous system,FALLS,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,1 [0.98-1.01],0.600042753636874,trans
Chapter VI Diseases of the nervous system,FALLS,CFD,Complement factor D,Wald ratio,1,0.94 [0.75-1.18],0.602159145696645,trans
Chapter VI Diseases of the nervous system,FALLS,TCN2,Transcobalamin-2,Inverse variance weighted,24,0.99 [0.97-1.02],0.605929242392893,trans
Chapter VI Diseases of the nervous system,FALLS,CD276,CD276 antigen,Inverse variance weighted,24,1.01 [0.97-1.05],0.607146747225403,trans
Chapter VI Diseases of the nervous system,FALLS,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.98 [0.89-1.07],0.622174891008624,trans
Chapter VI Diseases of the nervous system,FALLS,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,0.98 [0.91-1.06],0.62224327855735,trans
Chapter VI Diseases of the nervous system,FALLS,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.97 [0.88-1.08],0.623395666855493,trans
Chapter VI Diseases of the nervous system,FALLS,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.01 [0.98-1.04],0.623779793852388,trans
Chapter VI Diseases of the nervous system,FALLS,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.01 [0.98-1.03],0.624808021075939,trans
Chapter VI Diseases of the nervous system,FALLS,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.97 [0.87-1.09],0.626338689752514,trans
Chapter VI Diseases of the nervous system,FALLS,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,48,1 [0.98-1.01],0.626942334327407,trans
Chapter VI Diseases of the nervous system,FALLS,LGALS3,Galectin-3,Inverse variance weighted,15,0.99 [0.94-1.04],0.62941026289191,trans
Chapter VI Diseases of the nervous system,FALLS,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,34,0.99 [0.97-1.02],0.630096068920179,trans
Chapter VI Diseases of the nervous system,FALLS,CCN4,CCN family member 4,Inverse variance weighted,29,1.01 [0.98-1.03],0.630866824936819,trans
Chapter VI Diseases of the nervous system,FALLS,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.01 [0.96-1.07],0.637059474166646,trans
Chapter VI Diseases of the nervous system,FALLS,CDHR5,Cadherin-related family member 5,Inverse variance weighted,16,0.99 [0.94-1.04],0.638393810722485,trans
Chapter VI Diseases of the nervous system,FALLS,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.02 [0.94-1.11],0.651979497225519,trans
Chapter VI Diseases of the nervous system,FALLS,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.99 [0.92-1.05],0.658436995570355,trans
Chapter VI Diseases of the nervous system,FALLS,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,0.98 [0.89-1.08],0.661632254675849,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.99 [0.94-1.04],0.66384258136313,trans
Chapter VI Diseases of the nervous system,FALLS,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.96 [0.81-1.14],0.666223856740527,trans
Chapter VI Diseases of the nervous system,FALLS,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.02 [0.92-1.14],0.667507303073746,trans
Chapter VI Diseases of the nervous system,FALLS,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.95 [0.75-1.2],0.668695644309638,trans
Chapter VI Diseases of the nervous system,FALLS,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,0.99 [0.94-1.04],0.669574581332116,trans
Chapter VI Diseases of the nervous system,FALLS,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.03 [0.89-1.19],0.670747674848742,trans
Chapter VI Diseases of the nervous system,FALLS,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.01 [0.95-1.08],0.671257807364326,trans
Chapter VI Diseases of the nervous system,FALLS,FOLR2,Folate receptor beta,Inverse variance weighted,14,1.02 [0.94-1.1],0.678179746152856,trans
Chapter VI Diseases of the nervous system,FALLS,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.99 [0.96-1.02],0.678227564241259,trans
Chapter VI Diseases of the nervous system,FALLS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.01 [0.97-1.05],0.679285242284291,trans
Chapter VI Diseases of the nervous system,FALLS,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.02 [0.94-1.11],0.679523903410081,trans
Chapter VI Diseases of the nervous system,FALLS,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1 [0.98-1.02],0.680285757606409,trans
Chapter VI Diseases of the nervous system,FALLS,CPM,Carboxypeptidase M,Inverse variance weighted,19,0.99 [0.94-1.04],0.684975318861537,trans
Chapter VI Diseases of the nervous system,FALLS,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,1.01 [0.95-1.08],0.693687810990318,trans
Chapter VI Diseases of the nervous system,FALLS,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,0.98 [0.9-1.07],0.694054672218421,trans
Chapter VI Diseases of the nervous system,FALLS,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,Inverse variance weighted,35,0.99 [0.95-1.03],0.694775762211991,trans
Chapter VI Diseases of the nervous system,FALLS,GAST,Gastrin,Inverse variance weighted,9,0.99 [0.93-1.05],0.698456820325273,trans
Chapter VI Diseases of the nervous system,FALLS,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.99 [0.94-1.04],0.701897440197844,trans
Chapter VI Diseases of the nervous system,FALLS,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.96 [0.78-1.18],0.703494634565352,trans
Chapter VI Diseases of the nervous system,FALLS,PVR,Poliovirus receptor,Inverse variance weighted,3,0.97 [0.84-1.13],0.704586120323464,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.02 [0.94-1.1],0.708648058107918,trans
Chapter VI Diseases of the nervous system,FALLS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.03 [0.89-1.19],0.709648675735112,trans
Chapter VI Diseases of the nervous system,FALLS,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,0.99 [0.94-1.04],0.710834310409248,trans
Chapter VI Diseases of the nervous system,FALLS,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1 [0.98-1.03],0.71353325845504,trans
Chapter VI Diseases of the nervous system,FALLS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1 [0.98-1.03],0.715016344157878,trans
Chapter VI Diseases of the nervous system,FALLS,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.02 [0.9-1.16],0.71890799306877,trans
Chapter VI Diseases of the nervous system,FALLS,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.02 [0.9-1.17],0.719792925749833,trans
Chapter VI Diseases of the nervous system,FALLS,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.01 [0.95-1.08],0.720387110642919,trans
Chapter VI Diseases of the nervous system,FALLS,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,0.99 [0.97-1.02],0.722286026999413,trans
Chapter VI Diseases of the nervous system,FALLS,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,14,0.98 [0.9-1.08],0.723780543300383,trans
Chapter VI Diseases of the nervous system,FALLS,F3,Tissue factor,Inverse variance weighted,13,0.99 [0.91-1.07],0.724910702833196,trans
Chapter VI Diseases of the nervous system,FALLS,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.98 [0.85-1.12],0.728460177995757,trans
Chapter VI Diseases of the nervous system,FALLS,PLXNB2,Plexin-B2,Inverse variance weighted,12,1.01 [0.95-1.08],0.729227507920254,trans
Chapter VI Diseases of the nervous system,FALLS,LMNB2,Lamin-B2,Inverse variance weighted,8,1.02 [0.91-1.14],0.729864780634414,trans
Chapter VI Diseases of the nervous system,FALLS,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.99 [0.93-1.05],0.729887513998852,trans
Chapter VI Diseases of the nervous system,FALLS,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,0.99 [0.95-1.04],0.730442154285007,trans
Chapter VI Diseases of the nervous system,FALLS,COLEC12,Collectin-12,Inverse variance weighted,3,1.03 [0.88-1.2],0.730443766270314,trans
Chapter VI Diseases of the nervous system,FALLS,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1 [0.98-1.03],0.730519968506384,trans
Chapter VI Diseases of the nervous system,FALLS,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.01 [0.97-1.04],0.732791785707602,trans
Chapter VI Diseases of the nervous system,FALLS,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,0.99 [0.95-1.04],0.733846870234781,trans
Chapter VI Diseases of the nervous system,FALLS,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,1.01 [0.94-1.09],0.734807268541336,trans
Chapter VI Diseases of the nervous system,FALLS,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.01 [0.94-1.09],0.739100898078943,trans
Chapter VI Diseases of the nervous system,FALLS,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.98 [0.88-1.1],0.742290432584116,trans
Chapter VI Diseases of the nervous system,FALLS,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.03 [0.87-1.21],0.743026995460009,trans
Chapter VI Diseases of the nervous system,FALLS,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,1.01 [0.94-1.09],0.744631614990243,trans
Chapter VI Diseases of the nervous system,FALLS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.99 [0.92-1.06],0.745560945854894,trans
Chapter VI Diseases of the nervous system,FALLS,SHBG,Sex hormone-binding globulin,Inverse variance weighted,11,1.01 [0.96-1.07],0.746921893828015,trans
Chapter VI Diseases of the nervous system,FALLS,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.01 [0.93-1.11],0.750832040196711,trans
Chapter VI Diseases of the nervous system,FALLS,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.99 [0.93-1.06],0.753735153942322,trans
Chapter VI Diseases of the nervous system,FALLS,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.01 [0.92-1.11],0.760008237140902,trans
Chapter VI Diseases of the nervous system,FALLS,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,1.01 [0.95-1.07],0.762557916508729,trans
Chapter VI Diseases of the nervous system,FALLS,CHGA,Chromogranin-A,Inverse variance weighted,5,0.98 [0.84-1.14],0.763882852283374,trans
Chapter VI Diseases of the nervous system,FALLS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.99 [0.92-1.06],0.764561805086705,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.99 [0.95-1.04],0.764974087381936,trans
Chapter VI Diseases of the nervous system,FALLS,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,0.96 [0.74-1.25],0.765258990538334,trans
Chapter VI Diseases of the nervous system,FALLS,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.99 [0.91-1.07],0.766972041358069,trans
Chapter VI Diseases of the nervous system,FALLS,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,0.99 [0.95-1.04],0.768558596705473,trans
Chapter VI Diseases of the nervous system,FALLS,MMP8,Neutrophil collagenase,Inverse variance weighted,10,0.99 [0.93-1.06],0.771484549911523,trans
Chapter VI Diseases of the nervous system,FALLS,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.01 [0.93-1.11],0.774460067320047,trans
Chapter VI Diseases of the nervous system,FALLS,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.02 [0.91-1.13],0.777580874025266,trans
Chapter VI Diseases of the nervous system,FALLS,CALCA,Calcitonin,Inverse variance weighted,13,1.01 [0.94-1.08],0.780848301098002,trans
Chapter VI Diseases of the nervous system,FALLS,TNR,Tenascin-R,Inverse variance weighted,19,0.99 [0.96-1.03],0.781663019783178,trans
Chapter VI Diseases of the nervous system,FALLS,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,1.01 [0.92-1.11],0.782025497314426,trans
Chapter VI Diseases of the nervous system,FALLS,ITGAV,Integrin alpha-V,Inverse variance weighted,10,1.01 [0.91-1.13],0.78227426315353,trans
Chapter VI Diseases of the nervous system,FALLS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.97 [0.8-1.18],0.784173540519657,trans
Chapter VI Diseases of the nervous system,FALLS,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,3,0.96 [0.71-1.3],0.78837464609732,trans
Chapter VI Diseases of the nervous system,FALLS,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.01 [0.95-1.06],0.791019499855266,trans
Chapter VI Diseases of the nervous system,FALLS,PGF,Placenta growth factor,Inverse variance weighted,5,1.01 [0.93-1.1],0.792485290218149,trans
Chapter VI Diseases of the nervous system,FALLS,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.99 [0.9-1.09],0.794126847712088,trans
Chapter VI Diseases of the nervous system,FALLS,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,1.01 [0.91-1.13],0.80283815120984,trans
Chapter VI Diseases of the nervous system,FALLS,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.02 [0.86-1.22],0.804564844138689,trans
Chapter VI Diseases of the nervous system,FALLS,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.01 [0.91-1.13],0.806565961940932,trans
Chapter VI Diseases of the nervous system,FALLS,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.01 [0.94-1.08],0.809738695823765,trans
Chapter VI Diseases of the nervous system,FALLS,IL22,Interleukin-22,Inverse variance weighted,4,0.98 [0.86-1.12],0.811264102907654,trans
Chapter VI Diseases of the nervous system,FALLS,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,1.01 [0.94-1.08],0.812864566313416,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,1.01 [0.96-1.05],0.813619398237394,trans
Chapter VI Diseases of the nervous system,FALLS,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,1.01 [0.94-1.08],0.814082936328206,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.98 [0.86-1.12],0.815564288929124,trans
Chapter VI Diseases of the nervous system,FALLS,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.03 [0.79-1.35],0.816295819542704,trans
Chapter VI Diseases of the nervous system,FALLS,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1 [0.99-1.01],0.817881196490242,trans
Chapter VI Diseases of the nervous system,FALLS,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1 [0.97-1.04],0.817920758050858,trans
Chapter VI Diseases of the nervous system,FALLS,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.98 [0.82-1.17],0.818738096689585,trans
Chapter VI Diseases of the nervous system,FALLS,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.98 [0.82-1.17],0.820251191693762,trans
Chapter VI Diseases of the nervous system,FALLS,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.99 [0.91-1.08],0.82403592349927,trans
Chapter VI Diseases of the nervous system,FALLS,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.02 [0.85-1.22],0.82511818655307,trans
Chapter VI Diseases of the nervous system,FALLS,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.99 [0.93-1.06],0.831435548504532,trans
Chapter VI Diseases of the nervous system,FALLS,PRTN3,Myeloblastin,Inverse variance weighted,20,0.99 [0.94-1.05],0.834538867571944,trans
Chapter VI Diseases of the nervous system,FALLS,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1 [0.98-1.03],0.836042820809575,trans
Chapter VI Diseases of the nervous system,FALLS,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.96-1.03],0.836592527773863,trans
Chapter VI Diseases of the nervous system,FALLS,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,0.99 [0.91-1.08],0.844171021103363,trans
Chapter VI Diseases of the nervous system,FALLS,THBS2,Thrombospondin-2,Inverse variance weighted,15,1 [0.95-1.04],0.844887350096511,trans
Chapter VI Diseases of the nervous system,FALLS,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1 [0.95-1.05],0.845194862023473,trans
Chapter VI Diseases of the nervous system,FALLS,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,1.01 [0.93-1.09],0.846103414012114,trans
Chapter VI Diseases of the nervous system,FALLS,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.99 [0.89-1.1],0.849849912754805,trans
Chapter VI Diseases of the nervous system,FALLS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.99 [0.89-1.11],0.853943676448729,trans
Chapter VI Diseases of the nervous system,FALLS,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.99 [0.93-1.06],0.854145872003075,trans
Chapter VI Diseases of the nervous system,FALLS,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.02 [0.86-1.2],0.855838297976702,trans
Chapter VI Diseases of the nervous system,FALLS,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.01 [0.93-1.1],0.857340305012059,trans
Chapter VI Diseases of the nervous system,FALLS,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,14,1.01 [0.92-1.1],0.860951746807713,trans
Chapter VI Diseases of the nervous system,FALLS,IL10,Interleukin-10,Inverse variance weighted,4,1 [0.95-1.04],0.861821876431978,trans
Chapter VI Diseases of the nervous system,FALLS,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,1 [0.97-1.03],0.864541921100731,trans
Chapter VI Diseases of the nervous system,FALLS,MATN2,Matrilin-2,Inverse variance weighted,28,1 [0.98-1.02],0.873416886746266,trans
Chapter VI Diseases of the nervous system,FALLS,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.01 [0.92-1.1],0.87443876122882,trans
Chapter VI Diseases of the nervous system,FALLS,AREG,Amphiregulin,Inverse variance weighted,5,1.01 [0.92-1.11],0.874520152564781,trans
Chapter VI Diseases of the nervous system,FALLS,DSG2,Desmoglein-2,Inverse variance weighted,22,1 [0.97-1.04],0.877157669342367,trans
Chapter VI Diseases of the nervous system,FALLS,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.99 [0.84-1.17],0.8808787750824,trans
Chapter VI Diseases of the nervous system,FALLS,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.99 [0.89-1.11],0.881311915287853,trans
Chapter VI Diseases of the nervous system,FALLS,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1 [0.96-1.05],0.886613723490029,trans
Chapter VI Diseases of the nervous system,FALLS,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,1 [0.95-1.04],0.888096153337925,trans
Chapter VI Diseases of the nervous system,FALLS,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,1 [0.95-1.05],0.891068206210867,trans
Chapter VI Diseases of the nervous system,FALLS,BSG,Basigin,Inverse variance weighted,6,1.01 [0.83-1.23],0.892568202814526,trans
Chapter VI Diseases of the nervous system,FALLS,RSPO3,R-spondin-3,Inverse variance weighted,5,0.99 [0.91-1.09],0.895195962875729,trans
Chapter VI Diseases of the nervous system,FALLS,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,1.02 [0.8-1.29],0.898679382081997,trans
Chapter VI Diseases of the nervous system,FALLS,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1 [0.96-1.04],0.912549852762154,trans
Chapter VI Diseases of the nervous system,FALLS,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1 [0.92-1.08],0.914783720266816,trans
Chapter VI Diseases of the nervous system,FALLS,AMBP,Protein AMBP,Inverse variance weighted,5,1 [0.94-1.07],0.915582332002764,trans
Chapter VI Diseases of the nervous system,FALLS,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,1 [0.96-1.05],0.916739031145544,trans
Chapter VI Diseases of the nervous system,FALLS,SNCG,Gamma-synuclein,Inverse variance weighted,47,1 [0.98-1.02],0.917439647826263,trans
Chapter VI Diseases of the nervous system,FALLS,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.99 [0.8-1.23],0.918149787771002,trans
Chapter VI Diseases of the nervous system,FALLS,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.99 [0.82-1.2],0.919157049981115,trans
Chapter VI Diseases of the nervous system,FALLS,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.01 [0.91-1.11],0.919232451263139,trans
Chapter VI Diseases of the nervous system,FALLS,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,1 [0.96-1.05],0.926607370089238,trans
Chapter VI Diseases of the nervous system,FALLS,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1 [0.97-1.04],0.929732297178759,trans
Chapter VI Diseases of the nervous system,FALLS,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,1 [0.98-1.02],0.93370510761511,trans
Chapter VI Diseases of the nervous system,FALLS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.99 [0.84-1.18],0.940028586917582,trans
Chapter VI Diseases of the nervous system,FALLS,CTSD,Cathepsin D,Inverse variance weighted,7,1 [0.91-1.11],0.941643255088921,trans
Chapter VI Diseases of the nervous system,FALLS,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,0.99 [0.73-1.35],0.941888672841207,trans
Chapter VI Diseases of the nervous system,FALLS,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1 [0.95-1.06],0.944500615978325,trans
Chapter VI Diseases of the nervous system,FALLS,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.99 [0.76-1.29],0.945905496844126,trans
Chapter VI Diseases of the nervous system,FALLS,TNC,Tenascin,Inverse variance weighted,57,1 [0.98-1.02],0.947625618638904,trans
Chapter VI Diseases of the nervous system,FALLS,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.98 [0.58-1.67],0.951086890210231,trans
Chapter VI Diseases of the nervous system,FALLS,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1 [0.98-1.02],0.951594691468745,trans
Chapter VI Diseases of the nervous system,FALLS,CD59,CD59 glycoprotein,Inverse variance weighted,4,1 [0.89-1.13],0.95402094372332,trans
Chapter VI Diseases of the nervous system,FALLS,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1 [0.9-1.11],0.959811764391505,trans
Chapter VI Diseases of the nervous system,FALLS,FAM3C,Protein FAM3C,Inverse variance weighted,3,1 [0.88-1.13],0.960138228635799,trans
Chapter VI Diseases of the nervous system,FALLS,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1 [0.89-1.11],0.963179636604859,trans
Chapter VI Diseases of the nervous system,FALLS,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,7,1 [0.95-1.05],0.963462643917002,trans
Chapter VI Diseases of the nervous system,FALLS,CST3,Cystatin-C,Inverse variance weighted,3,1 [0.8-1.27],0.969133612848884,trans
Chapter VI Diseases of the nervous system,FALLS,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1 [0.93-1.08],0.977390451740691,trans
Chapter VI Diseases of the nervous system,FALLS,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1 [0.91-1.1],0.983724797363606,trans
Chapter VI Diseases of the nervous system,FALLS,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,1 [0.95-1.05],0.984925858649717,trans
Chapter VI Diseases of the nervous system,FALLS,CD48,CD48 antigen,Inverse variance weighted,14,1 [0.93-1.07],0.986035013278811,trans
Chapter VI Diseases of the nervous system,FALLS,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1 [0.96-1.04],0.986213317052811,trans
Chapter VI Diseases of the nervous system,FALLS,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1 [0.92-1.09],0.987860051238655,trans
Chapter VI Diseases of the nervous system,FALLS,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1 [0.92-1.09],0.989830308172858,trans
Chapter VI Diseases of the nervous system,FALLS,GFAP,Glial fibrillary acidic protein,Inverse variance weighted,14,1 [0.94-1.06],0.991776358576593,trans
Chapter VI Diseases of the nervous system,FALLS,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1 [0.77-1.3],0.994864680621971,trans
Chapter VI Diseases of the nervous system,FALLS,PTN,Pleiotrophin,Inverse variance weighted,3,1 [0.89-1.12],0.994976371425944,trans
Chapter VI Diseases of the nervous system,FALLS,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1 [0.83-1.2],0.998165475053553,trans
Chapter VI Diseases of the nervous system,FALLS,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1 [0.93-1.08],0.999048368684535,trans
